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Abstract 
  
The role of imported vegetables and spices in the epidemiology of antimicrobial resistance 
in Canada has been inadequately studied. In this investigation, resistant organisms from imported 
vegetables and spices in Saskatoon, Saskatchewan were investigated. 
A total of 147 vegetable and spice products imported from primarily Asian and African 
countries, were purchased from international markets in Saskatoon, Saskatchewan. Samples were 
selectively cultured for a panel of bacteria where resistance is known to be emerging. The 
proportion of samples positive for each organism were as follows: E. coli (n=15, 10.2%), 
Salmonella spp. (n=2, 1.4%), Enterobacter spp. (n=10, 6.8%), K. pneumoniae (n=2, 1.4%), 
Acinetobacter spp. (n=11, 7.5%), Pseudomonas spp. (n=10, 6.8%), S. aureus (n=7, 4.8%) and 
Enterococcus spp. (n=68, 46.3%). Antimicrobial susceptibility testing of isolates was conducted 
by broth micro dilution and agar dilution. Based on the susceptibility of each organism, isolates 
were then screened for resistance genes (β-lactamases and plasmid mediated quinolones resistance 
determinants) by PCR.  
Multidrug resistant Enterobacteriaceae were identified. Among other organisms, 
methicillin resistant S. aureus (MRSA) were identified. Resistance to the penicillins, 
cephalosporins, quinolones and aminoglycosides mediated by broad spectrum β-lactamases and 
plasmid mediated quinolone resistance determinants (PMQR) were identified. Broad spectrum β-
lactamase producers were cultured from 6/147 (4.1%) of samples tested. The most common 
enzymes found were CTX-M-15 (n=4), TEM-1 (n=2), SHV-142 (n=1) and SHV-106 (n=1). The 
PMQRs (QnrB1, QnrB2, QnrS1 and AAC(6’)-Ib-cr) containing isolates were cultured from 2/147 
(1.4%) of the samples. While all multi-drug resistant Enterobacteriaceae isolates were susceptible 
to meropenem and colistin, several non-fermenters were resistant to these drugs. However, none 
of these organisms produced carbapenemases or possessed mobilized colistin resistance 
determinants (MCR-1, MCR-2, MCR-3, MCR-4). Salmonella spp. were susceptible to the most of 
tested drugs. With the exception of two MRSA, the S. aureus isolates were susceptible to other 
non-beta lactam drugs. Enterococcus spp. isolates were resistant to various drugs but susceptible 
to ampicillin, penicillin and vancomycin. 
It was interesting to observe that all of the multi-drug resistant organisms originated from 
countries which are recognized to have a high prevalence of resistance. Therefore, further study 
is required to understand the extent of antimicrobial resistance transmission by imported 
vegetables and spices from these countries to Canada. 
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1. Introduction and Literature Review 
1.1. Antibiotic resistance 
1.1.1. Definition and the problem of antimicrobial resistance 
The introduction of antimicrobials has resulted in a tremendous impact on human and 
veterinary medicine. Ever since the discovery of antibiotics, antimicrobials have resulted in 
reduced morbidity and mortality in humans (Andersson & Hughes, 2010). This was associated 
with clinical benefits such as prevention of bacterial infections in cancer patients receiving 
chemotherapy and the development of organ transplantation procedures; antimicrobials are 
estimated to have increased human life expectancy by an estimated eight years between 1944 and 
1972 (Gafter-Gvili et al., 2012; Hancock & Knowles, 1998; Kabalin & Kessler, 1989). 
Antimicrobials also have contributed to improved control of infectious diseases in animals, and 
their growth promoting effects on livestock has been known since this effect was first reported in 
poultry in 1946 (Dibner & Richards, 2005; Gustafson & Bowen, 1997; Moore et al., 1946).     
Antimicrobials are defined as organic molecules that may be natural, semi-synthetic, 
synthetic substances that kill or inhibit the growth of microbes (E. D. Brown & Wright, 2016; 
Julian Davies & Davies, 2010; Giguère, 2013; Hashmi, Strezov, & Varma, 2017). Penicillin was 
the first discovered antibiotic by Alexander Fleming and the discovery of its antibacterial effect 
on Staphylococci and Streptococcus pyogenes was important breakthrough (Fleming, 1929). 
Subsequently streptomycin, which was identified in 1943, proved useful for the treatment of 
Mycobacterium tuberculosis; these discoveries brought about the golden era of antibiotics 
between 1950 and 1960 when a half of currently used compounds were discovered (Comroe, 
1978; Davies, 2006).  
As pioneering antibiotics have been discovered during the golden era of antibiotics, this 
breakthrough seemed to bring successful improvements in our quality of life; reduced bacterial 
infections in human and animal, and animal growth promotion (Andersson & Hughes, 2010; E. 
D. Brown & Wright, 2016; Dibner & Richards, 2005). However, as Alexander Fleming who 
discovered penicillin warned that bacteria could become resistant to antibiotics, the organisms 
became less susceptible to inhibitory action of the drugs (Fleming, 1945). Shortly after the 
discovery of penicillin, penicillin resistant S. aureus was identified in the 1940s (H. F. Chambers, 
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2001). In response to the resistance, other drugs were developed but resistance to those drugs 
followed soon after as well (Figure 1.1). What made the resistance follow so quickly were 
interactions of microorganisms to survive from their hazard including antimicrobial compounds. 
Moreover, the selective pressure in favour of antibiotic resistance is made worse by their 
overuse/misuse. Increasingly, multidrug resistance (MDR)/extensive drug resistance 
(XDR)/pandrug resistance (PDR) has been identified from the hospital patients. Neisseria 
gonorrhoea is one of the extreme cases that has developed their resistance to almost every 
antibiotic used to treat to this organism (Centers for Disease Control and Prevention, 2013). The 
exposure of antibiotics has been occurring not only in clinical settings, but also in agriculture and 
the environment, indicating the scale of selective pressure to microbes by antibiotics are vast and 
the distribution of resistant organisms is extensive (Hughes, 2014; Le Page, Gunnarsson, Snape, 
& Tyler, 2017; Sarmah, Meyer, & Boxall, 2006). For example, antibiotic residue in wastewater 
from healthcare facilities may enter wastewater treatment plant which could be a reservoir of the 
resistant organisms as the studies from Sweden and the US have reported (Börjesson, Matussek, 
Melin, Löfgren, & Lindgren, 2010; Rosenberg Goldstein et al., 2012). It may be because 
wastewater treatment is designed to remove solid waste and microbial contaminants but not 
antibiotics from untreated water. Resistant organism can also pass through treatment process as 
described by a study from India where resistant organisms were identified in tap water (Walsh, 
Weeks, Livermore, & Toleman, 2011). Moreover, antibiotics have been used in agricultural 
environments extensively as growth promoters for livestock which resulted in selective pressure 
on the existing microorganisms (Aarestrup, 1995; Bager, Madsen, Christensen, & Aarestrup, 
1997; Davies, 2008). Avoparcin, the glycopeptide antibiotic, was used as growth promoter for 
poultry and pigs since 1975 in Europe (Davies, 2008). In 1990s, Danish studies found that 
vancomycin resistant Enterococcus faecium emerged on farms that used avoparcin as a growth 
promoter (Aarestrup, 1995; Bager et al., 1997). Even though its use was banned in 1995 in 
Europe, multiple studies from Europe have found that vancomycin resistant Enterococci were 
still present on farms (Borgen et al., 2000; Garcia-Migura, Liebana, Jensen, Barnes, & Pleydell, 
2007; Ghidán et al., 2008; Novais et al., 2005). Vancomycin resistant E. faecium was still found 
from Danish broiler flocks in 2010 (Bortolaia, Mander, Jensen, Olsen, & Guardabassi, 2015). 
Although growth promoting applications for antibiotics were recently banned, the resistant 
bacteria selected for by these practices are still harboured by livestock, which may transmit to 
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human via food products (Food and Drug Administration, 2013; Larsen et al., 2011; Public 
Health Agency of Canada, 2016; US Food and Drug Administration, 2017; World Health 
Organization, 2011). Therefore, the problem of antimicrobial resistance (AMR) has now become 
one of the biggest threats on public health (World Health Organization, 2014).  
Not only has AMR resulted in increased morbidity and mortality, but additional financial 
costs associated with the requirement for lengthier hospitalizations, additional diagnostic 
investigations, more expensive treatments and infection control procedures (Gandra, Barter, & 
Laxminarayan, 2014). Although the human and financial cost of AMR in Canada have not been 
estimated thoroughly, one study has estimated the annual global incidence of mortality was 
estimated to be 700,000. It is expected to get worse if AMR is not tackled. The projected 
cumulative costs from 2014 through 2050 would be between 60-100 trillion US dollars. (O’Neil, 
2014; Public Health Agency of Canada, 2017b).  
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1.1.2. General mechanisms of antimicrobial resistance 
To fight back against antibiotics, bacteria have developed several resistance mechanisms to 
disrupt the action of antibiotics. Resistance has existed since ancient time to overcome actions of 
naturally-produced antimicrobial compounds in the environment due to their innate abilities. For 
example, enteric bacteria such as E. coli has an efflux pump called AcrAB system to pump out 
bile salts to survive in human intestine (Thanassi, Cheng, & Nikaido, 1997). This efflux system 
can also remove antibiotics to ensure bacterial survival at the time of antibitoc exposure. Other 
factors such as lack of drug targets, poor permeability of the bacterial cell and production of 
enzymes can all result in bacteria being intrinsically resistant to antibiotic compounds. For 
example, Pseudomonas spp. and Stenotrophomonas maltophilia are resistant to β-lactams by low 
permeability of the outer membrane and chromosomally encoded β-lactamases, respectively 
(Avison, Higgins, von Heldreich, Bennett, & Walsh, 2001). As this type of resistance occurs 
naturally without any change by selective pressure, it is termed as intrinsic resistance (Culyba, 
Mo, & Kohli, 2015). The resistance genes that confer the resistance in the organisms intrinsically 
can be mobilized by mobile gene elements. This can allow the resistance genes to transmit into 
the other organisms horizontally (Bennett, 2008). The transmitted genes in recipient organism 
then would be able to confer resistance to antibiotics which makes the organism non-susceptible 
anymore. These same resistance mechanisms, when in other bacteria which are not normally 
resistant, would be classified as acquired resistance. One of the examples is transfer of mobile 
resistance genes such as extended spectrum β-lactamase or AmpC β-lactamase encoding genes 
from either resistant organisms or outer environment into susceptible organisms. This could cause 
emergence of penicillins and cephalosporins resistance among Enterobacteriaceae.  
Resistance occurs by several common mechanisms: preventing access of antibiotics into their 
cell, altering the drugs targets to prevent binding and even enzymatic destruction or alteration as 
it is shown in Figure 1.2.  
Decreased permeability  
 Bacteria can reduce the penetration of antibiotics into the cell preventing access to drug 
targets. Many Gram-negative bacteria modify their cell membrane structure or alter porin 
expression to prevent most of antibiotics including β-lactams and aminoglycosides from crossing 
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their outer membrane (R. E. W. Hancock & Brinkman, 2002; Pechère & Köhler, 1999; Strateva 
& Yordanov, 2009). For example, Pseudomonas aeruginosa has low outer membrane 
permeability excluding most of the β-lactams including meropenem (Hancock & Brinkman, 
2002; Pechère & Köhler, 1999; Strateva & Yordanov, 2009). Similarly, decreased permeability is 
recognized among Gram-positive bacteria. Vancomycin intermediate S. aureus has been related 
to decreased entry of the drug into the cell through thickening of cell wall (Howden, Davies, 
Johnson, Stinear, & Grayson, 2010).  
Increased efflux 
 Another mechanism for Gram-negative bacteria to be resistant are efflux pumps. These 
efflux pumps can result in higher resistance with decreased permeability synergistically. 
Resistance nodulation cell division (RND) pumps, the multicomponent pumps located in 
cytoplasmic membrane in Gram-negative organisms, is one of the examples of efflux activity 
(Nikaido, 2001; Schweizer, 2012). These pumps exclude a broad spectrum of antibiotic 
molecules from many resistant Gram-negative organisms and can be acquired by susceptible ones 
(Schweizer, 2012). For example, Cml and Flo pumps conferring chloramphenicol resistance are 
found in several Gram-negative organisms such as E. coli, Enterobacter aerogenes, Klebsiella 
pneumoniae, Salmonella enterica serovar Typhimurium, P. aeruginosa and Vibrio cholerae 
(Schwarz, Kehrenberg, Doublet, & Cloeckaert, 2004). Among them studies have found flo type 
genes and cmlA type genes can be mobilized and confer the resistance in E. coli (Poirel, 
Decousser, & Nordmann, 2003; Poirel et al., 1999). The tetracyclines are the substrates for the 
TET family of pumps; over 10 different types in both Gram-negative and Gram-positive 
organisms are described (Poole, 2005). For example, TetA and TetB pumps are reported as the 
most prevalent Tet pumps in Acinetobacter baumannii and their determinants are transferrable to 
other Acinetobacter species (Huys et al., 2005; Mak, Kim, Pham, Tapsall, & White, 2009). 
Another study reported E. coli with tetM for the first time in 2004 which was almost identical to 
tetM from E. faecalis and also exist in transposons (Bryan, Shapir, & Sadowsky, 2004). This tetM 
gene also has been identified from Listeria monocytogenes and tetM exchange between two 
bacteria has been demonstrated in situ indicating its transferability among Gram-positives. In 
other Gram-positives, Tet38 in S. aureus is one example of a chromosomally located Tet gene, 
which is overexpressed when mutated (Truong-Bolduc, Dunman, Strahilevitz, Projan, & Hooper, 
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2005). QepA which is plasmid-mediated quinolone efflux pump confers resistance to 
ciprofloxacin and norfloxacin in Gram-negatives (Jacoby, Strahilevitz, & Hooper, 2014).   
  Altered drug binding sites  
 Some bacteria can modify the sites in their cell wall which drug molecules target, 
preventing drug binding and therefore inhibiting antibacterial activity. Some examples include 
methicillin-resistant S. aureus (MRSA), penicillin resistant Streptococcus pneumoniae, 
vancomycin-resistant Enterococci (VRE), and β-lactam resistant Neisseria gonorrhoeae 
(Cherazard et al., 2017; Miller, Munita, & Arias, 2014; Zapun, Contreras-Martel, & Vernet, 
2008). MRSA produces structurally modified penicillin binding proteins (PBPs) with reduced 
affinity of the β-lactams; similarly, S. pneumoniae and N. gonorrhoeae produce structurally 
modified PBPs as well which decrease affinity of penicillins and cephalosporins. (Bharat, 
Demczuk, Martin, & Mulvey, 2015; Cherazard et al., 2017; Cornick & Bentley, 2012; Pantosti, 
Sanchini, & Monaco, 2007; Smith et al., 2005; Zapun et al., 2008). VRE is resistant to 
glycopeptide antimicrobials due to its altered structure of peptidoglycan cell wall precursor 
component (D-alanine-D-alanine). It is this component in susceptible organisms that vancomycin 
targets to prevent cross-link of peptidoglycan chains and inhibit synthesis of the cell wall thereby 
having its effect (Miller et al., 2014). Quinolone resistance can also result from alterations in the 
antibiotic binding site. DNA gyrase and topoisomerase IV which maintain superhelical tension 
from DNA supercoiling to stabilize DNA synthesis are targeted by quinolones (Correia, Poeta, 
Hébraud, Capelo, & Igrejas, 2017; G A Jacoby & Medeiros, 1991). QnrA, which is one of 
plasmid-mediated quinolone resistance (PMQR) determinants, binds to gyrase holoenzyme and 
its subunits, GyrA and GyrB, to protect DNA gyrase. It also binds to topoisomerase IV 
holoenzyme and its subunits, ParC and ParE. Once QnrA-gyrase or QnrA-topoisomerase IV 
complex are formed, quinolone binding is prevented (Tran, Jacoby, & Hooper, 2005a, 2005b).    
Enzymatic degradation 
 Bacteria also can produce enzymes to inactivate antibiotics by either destroying or modify 
the drug. β-lactamases which hydrolyze the β-lactam ring in penicillins, cephalosporins and 
carbapenems are well-known examples of this mechanism. These enzymes are the most common 
mechanism of β-lactam resistance (Bush & Jacoby, 2010). As β-lactams have been widely used 
clinically, a wide variety of different β-lactamases have emerged. Important examples of these 
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enzymes in Gram-negatives include the extended-spectrum β-lactamases (ESBLs), AmpC β-
lactamases and enzymes with carbapenemase activity. ESBLs include the TEM, SHV (except 
parental TEM and SHV enzymes) and CTX-M. All ESBLs hydrolyze penicillins but TEM and 
SHV enzymes conduct limited hydrolyzation of cephalosporins and azteonam. In contrast, CTX-
M enzymes hydrolyze all 3rd generation of cephalosporins. AmpC β-lactamases such as CMY-2, 
hydrolyze an expanded spectrum of cephalosporins and cephamycins, and are not inhibited by β-
lactamase inhibitors (clavulanic acid) (Thomson, 2010). Carbapenemases, NDM, VIM, KPC and 
OXA varieties, hydrolyze carbapenems which have broader spectrum of antibiotic activity than 
penicillins and cephalosporins (Sekirov et al., 2016; Thomson, 2010). Enzyme-mediated 
resistance also has been identified in association with aminoglycoside and quinolone resistance. 
The AAC(6’)-Ib-cr enzyme, one of PMQR determinants, acts as an acetyltransferase to acetylate 
aminoglycosides (amikacin, kanamycin and tobramycin) and fluoroquinolones (ciprofloxacin and 
norfloxacin) (Jacoby et al., 2014).  
Mobility of antimicrobial resistance genes and acquired resistance 
In terms of the problem of AMR, mobility of AMR genes plays a major role allowing 
susceptible bacterial organisms to acquire the resistance mechanisms.    
Acquired resistance occurs when previously susceptible organisms (wild type organisms) 
develop or acquire resistance. Susceptible bacteria can become resistant by either mutating their 
chromosomal genes (spontaneous mutation, hypermutator and adaptive mutagenesis) or acquiring 
external genetic determinants from other resistant organisms (horizontal gene transfer) (Džidić, 
Šušković, & Kos, 2008). Horizontal gene transfer (HGT) is an important mechanism contributing 
to rapid and broad dissemination of AMR within or between species. HGT can occur by 
transformation, transduction and conjugation as it is described in Figure 1.2 (Bennett, 2008). 
First, bacterial cells can take up free resistance genes from extracellular environment, which is 
called natural transformation (von Wintersdorff et al., 2016). Transformation occurs when the 
recipient bacteria is exposed to altered environments such as growth conditions, nutrient access, 
cell density or starvation (Thomas & Nielsen, 2005; von Wintersdorff et al., 2016). Antibiotics 
can be one of the main contributors on altered extracellular environment. As antibiotics kill or 
inhibit the growth of the organisms, bacteria have strategies to survive from the stress caused by 
antibiotics. One of their strategies is to take mobile resistance gene elements from their outer 
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environment. (Charpentier, Polard, & Claverys, 2012). Bacteriophage mediated HGT, 
transduction occurs when bacteriophage replicates genomes (chromosomal DNA, plasmid DNA, 
transposons, gene cassettes) from their previous bacteria host into the phage head and transfers 
them to new bacteria host (Huddleston, 2014; Schwarz, Loeffler, & Kadlec, 2017). Transfer of 
this material can then occur following infection of a naïve cell. As bacteriophages have been 
identified to have broad host range, between not only different species but also different classes, 
transduction plays a significant role in the dissemination of resistance genes in microbial 
communities (Jensen et al., 1998; Mazaheri Nezhad Fard, Barton, & Heuzenroeder, 2011). The 
other HGT mechanism that covers host range between different species and classes is 
conjugation. Conjugation happens when contact between two bacterial cells is made; cell-to-cell 
contact is made by a pilus from donor bacterium forming a channel between the donor and 
recipient, and transfer of genetic elements can happen through the channel. DNA plasmids play a 
major role when it comes to conjugation for the transmission of important emerging resistance 
genes. Important examples of conjugative plasmids playing a role in the dissemination of 
antimicrobial resistance include the ESBL, AmpC β-lactamases, carbapenemases, PMQR 
determinants and colistin resistance (MCR-1) (Alba et al., 2018; Branger et al., 2018; Yang et al., 
2018). HGT has contributed to the rapid dissemination of resistance genes and the emergence of 
clinically problematic superbugs including broad spectrum β-lactamase producers, methicillin-
resistant Staphylococcus aureus and vancomycin resistant Enterococci.  
Other mobile gene elements, transposons and integrons, also contribute to HGT. 
Transposons incorporate DNA segments and transport the gene between bacterial chromosome 
and a plasmid or from a plasmid and another plasmid (Craig, 1997). They can be transferred from 
Gram-negatives to Gram-positives and vice versa (Bertram, Strätz, & Dürre, 1991). Transposons 
are known to contribute to the emergence of resistance in Gram-positives; vancomycin resistance 
genes are located in transposon (Tn1546) carried by plasmid (pIP816) and it can be transferred 
one Enterococcus spp. to other conducting inducible resistance in recipient Enterococcus spp 
(Arthur, Molinas, Depardieu, & Courvalin, 1993).  
Integrons also mobilize gene fragments as gene cassettes that are inserted to their 
recombination site by integron integrase. Gene cassettes can carry resistance genes, and various 
resistance genes can be carried on gene cassettes in integrons. One of the examples is 
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carbapenemase resistance genes (blaIMP, blaVIM, blaOXA) which have caused rapid spread of 
carbapenemase producing Enterobacteriaceae along with plasmid itself (Nordmann & Poirel, 
2002).  
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1.1.3. Extended spectrum β-lactamase and carbapenemases  
Broad spectrum β-lactamases are one of the major MDR threats in both community and 
healthcare settings. The spread, among Enterobacteriaceae, of genes encoding for β-lactamases 
allows for organisms such as E. coli and K. pneumoniae to become resistant to β-lactams 
(Karanika, Karantanos, Arvanitis, Grigoras, & Mylonakis, 2016; Reddy et al., 2007; Woerther, 
Andremont, & Kantele, 2017). The emergence of these enzymes is associated with serious 
therapeutic challenges since β-lactams are important drugs to treat bacterial pathogens; these 
drugs constitute 65% of the total antibiotic market worldwide (Thakuria & Lahon, 2013). β-
lactams consist of penicillins, cephalosporins, monobactams and carbapenems. The mechanism 
of action of β-lactams is to bind with PBPs on the cell membrane followed by inhibition of the 
cell wall synthesis (McDermott, Walker, & White, 2003). To prevent the activity of β-lactams, 
bacteria produce β-lactamases which hydrolyze the β-lactam ring to inactivate the antibiotics 
(Džidić et al., 2008).   
Under the Ambler classification scheme, β-lactamases are divided into four classes, A, B, C 
and D, depending on their amino acid motifs (Table 1.1). Class A β-lactamases are characterized 
by the presence of a serine residue at their active site (Ambler, 1980). Class A includes narrow 
spectrum β-lactamases (such as TEM-1, 2 and 13, and SHV-1), ESBLs (the other TEM and SHV 
varieties and CTX-M varieties), and KPC (K. pneumoniae carbapenemase), SME (Serratia 
marcescens Enzymes), IMI (IMIpenem hydrolysing β-lactamase) carbapenemases (Jacoby & 
Medeiros, 1991; Queenan et al., 2000; Yigit et al., 2001). While most of the class A β-lactamases 
hydrolyze 3rd generation cephlosporins and penicillins, the enzymatic activities of TEM and SHV 
are only limited to penicillins (Jacoby & Medeiros, 1991). Furthermore, class A carbapenemases 
including KPC, SME, IMI can hydrolyze monobactam, cephamycin and carbapenems along with 
penicillins and cephalosporins (Queenan et al., 2000; Yigit et al., 2001). Class B enzymes, 
metallo-β-lactamases, require bivalent metal ion, usually Zn2+, for their hydrolyzing activity and 
it includes NDM (New Delhi metallo-β-lactamase), VIM (Verona integron-encoded metallo-β-
lactamase), IMP (Imipenem resistant Pseudomonas) varieties (Ambler, 1980). These class B β-
lactamases can hydrolyze all β-lactams. Class C and D β-lactamases also have serine active site 
like the class A enzymes, but their functional traits are different. Class C (AmpC) have broader 
spectrum of activity on cephalosporins because their active site is more opened which makes 
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them bind to the bulkier side chains of cephalosporins easier than Class A (Jacoby, 2009). Class 
D includes oxacillinases (OXA varieties) which are more likely to conduct enzymatic activity 
against isoxazolyl-type penicillins, oxacillin, and carbapenem hydrolyzing oxacillinases such as 
OXA-48 and OXA-23 (June, Vallier, Bonomo, Leonard, & Powers, 2014; Ledent, Raquet, Joris, 
Van Beeumen, & Frère, 1993).    
The β-lactamase genes can be transmitted from β-lactamase producers to the non-producers 
thereby confering resistance to susceptible bacteria. Plasmids are one of the mobile gene 
elements that distribute β-lactamase genes to the susceptible bacteria effectively. The first 
reported plasmid-mediated β-lactamase was TEM in E. coli from Greece (TEM-1) (Patricia A. 
Bradford, 2001). Soon after this initial discovery reports of mobilization of SHV-1 from K. 
pneumoniae (encoded chromosomally) into E. coli (plasmid-mediated) were published (Patricia 
A. Bradford, 2001). These first reported β-lactamases were narrow spectrum β-lactamases which 
are not able to hydrolyze the broader spectrum of β-lactams such as the extended-spectrum 
penicillins or cephalosporins (Patricia A. Bradford, 2001). However, new groups of β-lactamases, 
ESBL, started emerging soon after broad spectrum penicillins and cephalosporins were 
introduced in both human and veterinary medicine (Elander, 2003; Shaikh, Fatima, Shakil, Rizvi, 
& Kamal, 2015; Tal Jasper, Coyle, Katz, & Marchaim, 2015). The first plasmid-mediated ESBL 
discovered was SHV-2 in K. pneumoniae found in Germany in the early 1980s (Kliebe, Nies, 
Meyer, Tolxdorff-Neutzling, & Wiedemann, 1985). The SHV-2 enzyme could hydrolyze a 
extended spectrum of β-lactams than could its parental enzyme, SHV-1. In 1987, a plasmid-borne 
CTX-1 (TEM-3 under current nomenclature) was identified to confer resistance to cefotaxime 
(3rd generation cephalosporin), which was a broader spectrum of hydrolysis than its parent 
enzymes, TEM-1 or TEM-2 (Sirot et al., 1987). In contrast, the CTX-M type β-lactamases, which 
did not evolve from narrow spectrum parental enzymes, can hydrolyze 3rd generation 
cephalosporins. The first CTX-M was identified in cefotaxime resistant E. coli from Japan in 
1988, and was called FEC-1 (Matsumoto, Ikeda, Kamimura, Yokota, & Mine, 1988). One year 
later cefotaxime resistant E. coli was also isolated from Germany in 1989 and in this case the 
identified β-lactamase was called CTX-M-1 (Bauernfeind, Grimm, & Schweighart, 1990). Since 
then, over 170 CTX-M variants have been identified (Lahey Clinic, 2017). Their hydrolytic 
spectrum includes penicillins, 2nd and 3rd generation cephalosporins, and they are primarily 
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identified among Enterobacteriaceae (including K. pneumoniae, E. coli and Proteus mirabilis) 
(Tal Jasper et al., 2015).  
Plasmid-mediated AmpC (blaCMY-2) enzymes are also frequently encountered, these genes are 
typically encoded chromosomally in Enterobacter, Citrobacter, Serratia but also can be 
mobilized. They are now found in other Enterobacteriaceae as well. The first plasmid-mediated 
AmpC β-lactamase that was characterized was CMY-1 in K. pneumoniae isolated from a patient 
in South Korea (Bauernfeind, Schweighart, & Chong, 1989). The resistance spectrum of CMY-1 
includes cephamycin along with penicillins, cephalosporins, which is broader spectrum than 
ESBLs. Besides CMY-1, other plasmid-mediated AmpC β-lactamases (CMY, FOX, ACT, MOX, 
ACC, DHA variants) also started to be identified globally (Bauernfeind, Schneider, Jungwirth, 
Sahly, & Ullmann, 1999; P. A. Bradford et al., 1997; Gaillot, Clément, Simonet, & Philippon, 
1997; Gonzalez Leiza et al., 1994; Horii et al., 1993). Since the 1990s, CMY-2 has become the 
most prevalent plasmid-mediated AmpC β-lactamases (Bauernfeind, Stemplinger, Jungwirth, & 
Giamarellou, 1996; Denisuik et al., 2013; Philippon, Arlet, & Jacoby, 2002; Sidjabat et al., 2009).  
More recently, the emergence of other β-lactamases with broader hydrolytic spectrum 
including carbapenemases have been identified. These enzymes are particularly problematic 
because the carbapenems are last-resort drugs with a very broad spectrum of activity. The first 
identified carbapenemase producing Enterobacteriaceae was E. cloacae producing NmcA 
imipenem-hydrolyzing β-lactamase (IMI-1) in 1984, a year before the clinical use of imipenem 
was approved (Rasmussen et al., 1996). Shortly after, in 1991, the plasmid-mediated 
carbapenemase, VIM-1, was identified from P. aeruginosa in Japan. This was followed by the 
discovery of ARI-1 (OXA-23 under current nomenclature) from A. baumannii in the UK in 1995 
and KPC-1 from K. pneumoniae in the US in 2001 (Donald, Scaife, Amyes, & Young, 2000; 
Scaife, Young, Paton, & Amyes, 1995; Watanabe, Iyobe, Inoue, & Mitsuhashi, 1991; Yigit et al., 
2001). Additional types of carbapenemase have subsequently been identified including OXA-48, 
the most common carbapenemase among OXA types, from K. pneumoniae in Turkey in 2004, 
and NDM-1 from K. pneumoniae in Sweden, which originated in India in 2008 (Poirel, Héritier, 
Tolün, & Nordmann, 2004; Yong et al., 2009). All IMP, VIM, KPC and NDM types successfully 
hydrolyze carbapenems along with almost all the other classes of β-lactams (Daikos et al., 2014; 
Qureshi et al., 2012; Tumbarello et al., 2012; Zarkotou et al., 2011). The OXA-48 type 
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carbapenemaess hydrolyze the penicillins and carbapenems but not the cephalosporins which can 
make them difficult to be detected in vitro (Doi & Paterson, 2015; Poirel, Potron, & Nordmann, 
2012).  
 The dissemination of ESBL and carbapenemase-producing Enterobacteriaceae worldwide 
has been dramatic. In the US, 140,000 healthcare-associated Enterobacteriaceae infections occur 
each year, nearly 26,000 (19%) of them are ESBL producers and 9,000 (6%) of them were 
carbapenem resistant according to the report from Centers for Disease Control and Prevention 
(CDC) (Centers for Disease Control and Prevention, 2013). In Europe, ESBL and 
carbapenemase-producing Enterobacteriaceae were reported by the European Antimicrobial 
Resistance Surveillance Network (EARS-Net). Data are reported as EU/EEA (European 
Union/European Economic Area) population-weighted mean which is determined by “applying 
population-based weights to each country’s data before calculating the arithmetric mean for all 
reporting countries" (European Centre for Disease Prevention and Control, 2017). In the 2016 
EARS-Net report, based on the highest EU/EEA population-weighted mean, 57.4%, 12.4% and 
less than 0.1% of E. coli isolates were aminopenicillin, 3rd generation cephalosporin and 
carbapenem resistant respectively. Whereas, 25.7% and 6.1% of K. pneumoniae isolates were 
resistant to the 3rd cephalosporins and carbapenems respectively based on the highest EU/EEA 
population-weighted mean (European Centre for Disease Prevention and Control, 2017). 
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1.1.4. Methicillin-resistant Staphylococcus aureus  
Methicillin-resistant S. aureus (MRSA) is another superbug frequently identified from both 
health and community settings. S. aureus is frequently implicated in skin, soft-tissue, respiratory, 
bone, join and endovascular infection and sepsis (Lowy, 1998; Otto, 2012). Although most of the 
infections caused by MRSA are not different from the ones by methicillin-susceptible S. aureus 
(MSSA), MRSA is associated with increased mortality rates, increased treatment costs, and 
prolonged stays in the hospital (Hanberger et al., 2011; Labreche et al., 2013). Soon after the 
discovery of penicillin, penicillin-resistant S. aureus emerged and a year after of methicillin 
clinical usage began in 1960, MRSA was detected (H. F. Chambers, 2001; Jevons, Coe, & 
Parker, 1963). MRSA produces the novel PBP (PBP2a) which has lower affinity for β-lactam 
drugs rendering these isolates resistant to the entire drug class (Hartman & Tomasz, 1981).  
Methicillin resistance is encoded by the mec family of genes (mecA, mecB, mecC and mecD); 
mecA and mecC are reported to confer the resistance in MRSA (Baba et al., 2009; Katayama, Ito, 
& Hiramatsu, 2000; Paterson, Harrison, & Holmes, 2014; Schwendener, Cotting, & Perreten, 
2017). The mec genes are located in staphylococcal chromosomal cassette (SCCmec) and the 
SCCmec is mobilizable by the actions of the ccr genes which allow excision and integration 
(Hartman & Tomasz, 1981; Katayama et al., 2000; Paterson et al., 2014). MRSA started 
circulating in the hospitals in the UK, Denmark and the US between 1960 and 1970 (Barrett, 
McGehee, & Finland, 1968; Crisóstomo et al., 2001; Stewart & Holt, 1963). Strains of MRSA 
found in the hospitals of the US in the 1970s and ‘80s, made their way out of health care settings, 
disseminating worldwide in both hospitals and the community (Henry F. Chambers & Deleo, 
2009). Recent CDC reports from the US indicated that there were 80,461 invasive MRSA 
infections and 11,285 MRSA infection-related deaths in 2011 in the US (Centers for Disease 
Control and Prevention, 2013). In Europe, the prevalence of MRSA infection has been reported 
to range between 1.2% and 50.5% in 2016. Overall, 3.7% of S. aureus isolates were MRSA based 
on the highest EU/EEA population-weighted mean (European Centre for Disease Prevention and 
Control, 2017).  
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1.1.5. Vancomycin resistant Enterococci 
Enterococcus species are normal inhabitants of the intestinal tract of humans and animals and 
they are also ubiquitous in the environment (Ahmed & Baptiste, 2018; Ranotkar et al., 2014). 
Although they are commensal bacteria in the human gastrointestinal tract, they can cause 
opportunistic infections including urinary tract infections, endocarditis, surgical wound 
infections, bacteraemia and sepsis (Beukers et al., 2017). Enterococcus faecalis and E. faecium 
are the most commonly isolated organisms from clinical infections (Arias & Murray, 2012). They 
are intrinsically resistant to various drugs including cephalosporins (Arias & Murray, 2012; 
Kristich, Rice, & Arias, 2014). To overcome MDR Enterococcus spp., vancomycin started to be 
used as alternative to penicillins to treat infections in the US in 1958 (Roland Leclercq, Derlot, 
Duval, & Courvalin, 1988; Levine, 2006). However, vancomycin resistant E. faecium was first 
reported in England in 1988 and the transferability of the resistance by a plasmid was identified 
in the US in 1987 (Roland Leclercq et al., 1988; Uttley, Collins, Naidoo, & George, 1988). 
Subsequently, vancomycin resistant enterococci (VRE) continued to emerge in the US as its 
percentage among enterococci isolates increased from 0.3% and 0.4% in 1989 to 15.4% and 
23.4% in the hospitals and intensive care units by 1997, respectively (Méndez-Alvarez, Pérez-
Hernández, & Claverie-Martín, 2000). The spread of VRE is the result of various genes, vanA, 
vanB, vanC, vanD and vanE (Kristich et al., 2014). vanA, which is the most problematic can be 
found in E. faecium and E. faecalis and it imparts high resistance to vancomycin and teicoplanin, 
the other glycopeptide drug along with vancomycin (Qu et al., 2009). It can be mobilized by 
mobile genetic elements (plasmid, transposons) and acquired by susceptible enterococci. vanB 
also can be found in E. faecium and E. faecalis and is transferrable by plasmid and transposons. 
Unlike vanA, it doesn’t confer resistance to teicoplanin (Quintiliani & Courvalin, 1994). vanC, 
vanD and vanE, on the other hand, show intermediate resistance. (Fines, Perichon, Reynolds, 
Sahm, & Courvalin, 1999; R Leclercq, Dutka-Malen, Duval, & Courvalin, 1992; Navarro & 
Courvalin, 1994; Perichon, Reynolds, & Courvalin, 1997). vanC is found on the chromosomes of 
E. gallinarum, E. casseliflavus and E. flavescens which are infrequently implicated species in 
human infections (Leclercq, Dutka-Malen, Duval, & Courvalin, 1992; Navarro & Courvalin, 
1994). vanC confers low levels of intrinsic resistance in E. casseliflavus and E. flavescens and 
high intrinsic resistance in E. gallinarum which are infrequently implicated species in human 
infections (Leclercq et al., 1992; Navarro & Courvalin, 1994). vanD and vanE are acquired genes 
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in E. faecium and E. faecalis respectively but not commonly identified and confer low resistance 
to vancomycin and teicoplanin (Fines et al., 1999; Perichon et al., 1997). 
 The incidence of VRE in the US remains high, 30% of enterococcal infection per year are 
reported to be vancomycin resistant including 77% of E. faecium and 9% of E. faecalis, resulting 
in 650 and 200 deaths respectively (Centers for Disease Control and Prevention, 2013). 
Meanwhile, according to EARS-Net report in 2016 the EU/EEA population-weighted mean 
percentage for vancomycin resistant E. faecium and E. faecalis were 11.8% and 30.5% in Europe 
(European Centre for Disease Prevention and Control, 2017). Alternative treatments for VRE 
include quinupristin-dalfopristin, linezolid and daptomycin. However, use of these drugs would 
bring new emergence of resistance and make it even harder to treat VRE (Arias & Murray, 2012). 
 
 
1.2. Epidemiology of foodborne antimicrobial resistance in Canada 
1.2.1. Transferability of antimicrobial resistance from food  
Food has been recognized as a potential source of resistant bacteria such as E. coli, 
Salmonella, Campylobacter, Vibrio species since the food can be contaminated with them either 
directly or indirectly during pre-processing, processing, distribution, food preparation and 
consumption (Centers for Disease Control and Prevention, 2016, 2018). In Canada, the Canadian 
Integrated Programs for Antimicrobial Resistance Surveillance (CIPARS) program monitors 
resistant E. coli, Salmonella spp. and Campylobacter from farm, abattoir and meat products since 
the early 2000s. For example, MDR E. coli and Salmonella spp. resistant to penicillins and 
cephalosporins have been identified from farm chickens, abattoir chickens and retail chicken 
meats between 2003 and 2015 in Ontario (Agunos et al., 2018). Other researchers have found 
MRSA on pork both before and after processing (scalding, skinning, pasteurizing and washing) 
obtained from commercial pork processing plants across the Canada in 2010 and 2011 (Narvaez-
Bravo et al., 2016). All these identified resistant bacteria from meat could be transmitted by 
complex interactions between and within humans, animals, and the environment. The primary 
route of meat contamination though is fecal contamination which can include enteric pathogens 
such as E. coli, Salmonella and Campylobacter spp. The animal carcass can be exposed to 
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ingesta, feces and soil, which contain enteric pathogens, during the slaughter process resulting in 
contamination of the meat if washing during processing is not done properly (Ashby et al., 2003; 
Yalçin, Nizamlioǧlu, & Gürbüz, 2001). Given resistant enteric bacteria from gastrointestinal 
tracts and feces of food animals are the primary source of contamination for meat, they have been 
one of the main targets for identifying resistant bacteria in farm surveillance by CIPARS 
(Government of Canada, 2017). 
Furthermore, on the farm, the lack of cleaning/disinfection practices or contact with 
environmental factors such as dust or water can also contribute to transmission of resistant 
bacteria (Agunos et al., 2018; Schulz et al., 2016). The contacts between animals and farm 
personnel, truck drivers during transportation to slaughterhouse and abattoir personnel may also 
contribute to further disseminaton of resistant organisms (Agunos et al., 2018; Lassok & 
Tenhagen, 2013; Molla et al., 2012). Use of antibiotics maintains resistance and applies pressure 
for the continued development of resistance (Holman & Chénier, 2013). Then, the transmission 
of organisms from one animal to the other in confined environments allows for the resistant 
organisms to be maintained within the food animal population (McEwen & Fedorka-Cray, 2002).     
 Food can also be contaminated with the resistant organisms by food handlers during the 
processing and distribution stages. For example, penicillin and cephalosporin resistant E. coli 
were isolated from migrant food handlers in Qatar (Eltai et al., 2018). Another study from 
Malaysia showed that MDR E. coli and S. aureus were isolated from food handlers’ hand before, 
during and after ready-to-eat foods preparation (Tan, Lee, & Mahyudin, 2014). These studies 
indicate that processing and distribution by food handlers could potentially result in the 
transmission of resistant organisms to the meat products and that this occurrence is more likely 
there if hygiene practices are poor. 
Less attention has been paid to the identification of antibiotic resistant bacteria from 
vegetables than in meat. Antimicrobial resistant oxidase-positive Gram-negatives (P. fluorescens, 
P. putida, Sphingobacterium spp. and A. baumannii) were isolated from Ontario-grown Romaine 
lettuce, Savoy spinach and alfalfa sprouts; isolates were resistant to amipicillin, cephalothin, 
chloramphenicol, streptomycin, nalidixic acid, kanamycin and gentamicin (Bezanson, MacInnis, 
Potter, & Hughes, 2008). In British Columbia, E. coli were isolated from lettuce purchased from 
farmers markets, 35% were resistant to amikacin, sulfonamides and nalidixic acid (Wood, Chen, 
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Friesen, Delaquis, & Allen, 2015). Similar investigations have been done in other countries as 
well. For example, 13% of E. coli from fruits and vegetables purchased from local retail markets 
and wholesale market in Osaka, Japan from 2005 to 2008 were resistant to cephalotin (Wang, 
Nakamura, Kage-Nakadai, Hara-Kudo, & Nishikawa, 2017). E. coli isolated, described as 
diarrheagenic, from whole, cut and salad nopalitos (a dish made with nopal, a type of cactus) 
purchased from public markets were identified from Mexico in 2016 (Gómez-Aldapa et al., 
2016). The isolates were resistant to amoxicillin/clavulanic acid, colistin and gentamicin (Gómez-
Aldapa et al., 2016). A study from Benin identified more E. coli were isolated from lettuce, 
cabbage, great nightshades and carrots purchased from market garden sites during dry season 
than during the rainy season and that more than 70% of the isolates were resistant to 
amoxicillin/clavulanic acid, 3rd generation cephalosporins and nalidixic acid (Moussé et al., 
2015). The prevalence of resistant bacteria may depend on factors from pre-harvest such as 
irrigation water or sewage sludge which is used for soil fertilization (Araújo et al., 2017; Rahube 
et al., 2014, 2016). A study from Portugal demonstrated that irrigation water may transmit 
resistant organisms to vegetables as the same sequence types of MDR E. coli were detected both 
in the water and on the vegetables (Araújo et al., 2017). Two studies in Canada have 
experimentally demonstrated that harvested vegetables grown in sewage sludge-treated soil had 
more types and abundance of resistance genes and mobile genetic elements than the ones grown 
in soil without sewage sludge treatment (Rahube et al., 2014, 2016).  
 
1.2.2. Role of imported food on antimicrobial resistance transmission 
Multiple factors can contribute to the contamination of food sources and products by 
resistant organisms which can then be transmited to humans (Figure 1.3). Besides domestically 
sourced AMR, the import and export of foods may play a role in the global distribution of 
resistant organisms. Because food has been actively imported and exported across the world, it is 
possible that resistant organisms can be transmited from one country to the other and this 
phenomenon has been reported by studies from around the world. For example, ESBL producing 
E. coli were identified from chicken imported from Brazil and purchased in Japan (Nahar et al., 
2018). In Germany, ESBL and AmpC producing E. coli isolates were identified on both legally 
and illegally imported pork and poultry products from Brazil, Chile, and Egypt (A. Müller et al., 
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2018). A study in the US identified Salmonella spp. from imported vegetables, fruits, meats and 
seafood from Taiwan, Indonesia, Vietnam, China, Australia and Pakistan (Bae, Kweon, & Khan, 
2016). The isolates were resistant to multiple drugs including ampicillin, ciprofloxacin, nalidixic 
acid, gentamicin, tetracycline (Bae et al., 2016). In Canada, E. cloacae were identified from 
bivalve mollusks imported from Vietnam harbouring blaNDM-1 along with blaTEM and blaOXA-1 
(Janecko et al., 2016). Carbapenemase (OXA-48) producing non-pathogenic bacteria, 
Stenotrophomonas spp., S. maltophila, Myroides odoratimimus and P. putida, were identified 
from seafood imported from China and Korea to Canada as well (Morrison & Rubin, 2015).  
As all these studies have identified, serious pathogenic bacteria resistant to clinically 
important antibiotics can be transferred to humans from other countries via imported foods. 
Furthermore, it may be inevitable that the countries with a low prevalence of resistance will be 
likely to face an increasing number of unexpected AMR organisms being transferred into the 
country from the regions with a higher prevalence of the resistance.  
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Figure 1. 3. Epidemiology of antimicrobial resistance. Besides its transmission among clinical 
and community settings, antimicrobial resistance transmission to human occurs via interactions 
with environment, animals and foods. Among many other factors, direct transmission may occur 
from water consumption, swimming, contacting companion and wildlife animals and domestic or 
imported food consumption. The range of the transmission can be extended by travellers and 
imported goods (e.g. imported foods). Figure is adopted from Canadian Integrated Program for 
Antimicrobial Resistance Surveillance (CIPARS). 
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1.3. Antimicrobial resistance studies on imported food in Canada 
1.3.1. Current resistance surveillance by CIPARS and studies in Canada 
Canada has a national antimicrobial resistance surveillance program called CIPARS 
which has been monitoring resistant bacterial organisms from farm, abattoir and retail along with 
human clinical Salmonella isolates across the country since its establishment in 2002 
(Government of Canada, 2017). British Columbia, the prairie provinces (Alberta, Saskatchewan, 
Manitoba), Ontario and Quebec have been targeted since these regions are major pork and 
poultry producers (Government of Canada, 2017). E. coli, Salmonella spp. and Campylobacter 
spp. are the main enteric pathogens colonized in gastrointestinal tracts of domestic animals and 
are easily transmited to other animals on farm or at the abattoir by fecal contamination. 
Therefore, CIPARS is targeting enteric bacteria that may be resistant to the most critically 
important antimicrobials to human health as identified by the World Health Organization (WHO) 
including the 3rd and 4th generation cephalosporins and fluoroquinolones (Agunos et al., 2018; 
Collignon et al., 2016; Government of Canada, 2017). The recent 2015 CIPARS report has 
focused on ceftriaxone resistance in non-typhoidal Salmonella spp. and E. coli, and 
fluoroquinolone resistance in Campylobacter spp. This is because 3rd and 4th   generation 
cephalosporins and fluoroquinolones are considered as Category I (very high importance) for the 
treatment of serious bacterial infections in human by Health Canada (Government of Canada, 
2009). 
CIPARS identified a decreasing rate of ceftriaxone resistant E. coli and Salmonella spp. in 
farm, abattoir and retail chicken since 2013 from all provinces (Government of Canada, 2017). 
This was identified after the Chicken Farmers of Canada implemented a policy that no longer 
allows the use of Category I antimicrobials for preventative use in chicks (Government of 
Canada, 2017). No flocks participating in the CIPARS broiler chicken program in 2015 reported 
any use of Category I antimicrobials (Government of Canada, 2017). Levels of ciprofloxacin 
resistant Campylobacter spp., isolated from chickens, varied across Canada; interestingly the 
reason for the persistence of this resistance is unexplained as CIPARS has reported no 
fluoroquinolone use on broiler chicken farms participating in CIPARS since 2013 (Government 
of Canada, 2017). CIPARS also identified increasing rates of MDR Salmonella spp., resistant up 
to 6 classes among 7 classes of tested antimicrobials (β-lactams, aminoglycosides, quinolones, 
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macrolides, phenicols, folate pathway inhibitors and tetracyclines) from cattle (Quebec, Ontario 
and Alberta) and pigs (Manitoba, Quebec, Ontario) (Government of Canada, 2017). 
Overall, the resistance in food animals in Canada has been monitored well and various 
trends can be identified both nationally and regionally annually. However, one important 
limitation to the current CIPARS program is the lack of representation from the Atlantic region. 
In the case of clinical Salmonella isolates, another limitation is that repeated submissions from 
the same farm or animal in disease outbreak events may bias the sample population (Government 
of Canada, 2017).  
The gaps from CIPARS could be filled by investigator driven research projects. These 
independent research projects can identify more resistant organisms than CIPARS do and also 
conduct further characterization. While the targets of CIPARS are E. coli, Salmonella spp. and 
Campylobacter spp., independent projects have the flexibility to target additional organisms such 
as S. aureus or Clostridium difficile (Narvaez-Bravo et al., 2016; Rodriguez-Palacios, Staempfli, 
Duffield, & Weese, 2007). Furthermore, the identification of resistance genes or other molecular 
characterization can be more readily done in the context of independent research than in routine 
surveillance (Narvaez-Bravo et al., 2016; Rodriguez-Palacios et al., 2007). Other types of food 
such as vegetables can also be targeted by other independent studies to identify the resistant 
organisms belonging to taxa (e.g. Pseudomonas spp., Acinetobacter spp.) which CIPARS has not 
included (Bezanson et al., 2008; Wood et al., 2015). 
   
1.3.2. Resistance surveillance gap from imported foods    
There are gaps within CIPARS with regard to certain resistant bacterial organisms and 
food sources. Recently, the Canadian Antimicrobial Resistance Surveillance System (CARSS) 
was created by Public Health Agency of Canada (PHAC) to try to cover the knowledge gaps 
regarding the AMR problem in Canada by integrating data from various programs. Among the 
data integrated by CARSS, one focus was to identify carbapenemase producing 
Enterobacteriaceae from imported foods. Researchers have done screening for carbapenemase 
producing bacteria from imported foods (retail seafoods, dried spices and dried chicken pet 
treats) between 2011 and 2015 (Janecko et al., 2016; Public Health Agency of Canada, 2018a). 
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As a result, two and three bivalve mollusks containing E. cloacae harbouring the NDM-1 gene 
and E. cloacae harbouring the IMI-1 gene respectively have been identified. Additionally, E. 
cloacae and E. aerogenes harbouring the IMI-1 and IMI-2 genes were identified from imported 
shrimp (Janecko et al., 2016; Public Health Agency of Canada, 2018a). The VCC-1 gene, a novel 
carbapenemase gene, from V. cholerae was isolated from imported retail shrimp (Mangat et al., 
2016; Public Health Agency of Canada, 2018a). E. coli harbouring the mobile colistin resistance 
gene, mcr-1, were isolated from two imported seafood products from a research project that 
spanned from 2010 to 2016 (Public Health Agency of Canada, 2018a). One recent study found 
nitrofurantoin resistant E. faecalis and ciprofloxacin, erythromycin, linezolid, nitrofurantoin, 
penicillin and tetracycline resistant E. faecium in imported herbs, leafy greens and spinach 
purchased in 2011 (Allen et al., 2013). Although these findings highlight the importance of 
monitoring antibiotic resistance in imported foods, there is still less information regarding 
imported foods as reservoirs for resistant organisms. Given that the role of antibiotic resistance 
coming from imported food has been inadequately investigsted in Canada, more focus on 
imported food sources and products with broader spectrum of resistant organisms as targets may 
provide a better understanding of this route of antibiotic resistance transmission to our 
community.    
 
 
 
 
 
 
 
 
 
 
27 
 
2. Objectives 
 Food is a potential reservoir for bacterial organisms and a vehicle for bacteria which are 
resistant to antimicrobials or their resistance genes to be transmitted into humans. This 
transmission can be extended by the import and export of food items between countries. 
International trade could result in the transmission of resistance from high to low prevalence 
countries, or the introduction of novel resistance genes. In Canada, CIPARS has been main 
surveillance program to identify antimicrobial resistant organisms from food sources and 
products. However, core surveillance only focuses on domestically produced food animals and 
locally available meat products; therefore, missing seafood, dried spices, vegetables and imported 
non-meat products as possible sources of AMR organisms. Researchers have found 
carbapenemase-producers from imported seafoods and dried spices between 2011 and 2015, 
demonstrating these products as an important source of AMR. This thesis focuses on identifying 
antimicrobial resistant organisms from imported vegetables and spices with two main objectives:  
• To identify the presence of antimicrobial resistant organisms in imported vegetables and 
spices purchased at international markets in Saskatoon, Saskatchewan 
• To identify and characterize resistance genes present in foodborne organisms 
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3.1. Introduction 
Antibiotic resistance is one of the most problematic public health issues in the world. 
Antimicrobial resistance (AMR) has disseminated into people, companion and agricultural 
animals, wildlife, wastewater and food products (Doi, Iovleva, & Bonomo, 2017). Moreover, 
selective pressure by antibiotic use in both human and veterinary medicine promotes the 
emergence of antimicrobial resistant organisms. The emergence can be facilitated by horizontal 
gene transfer (HGT) from other resistant bacteria or mobile gene elements in outer environments 
being acquired by susceptible bacteria (Bennett, 2008). Among the contributors for both the 
distribution and emergence, food sources/products can be an effective reservoir for both the 
resistant organisms and mobile genes. Fecal contamination is the primary route of resistance 
transmission particularly related to contamination of enteric pathogens such as E. coli, 
Salmonella spp. and Campylobacter spp. (Ashby et al., 2003). These resistant pathogens from 
ingesta or feces can contaminate the animal carcasses on farm or at the abattoir (Ashby et al., 
2003; Yalçin et al., 2001). Besides food animals, vegetables are exposed to various factors. Dust, 
soil, irrigation water, sewage sludge treatment, wild animals or birds, and direct contact with 
farm workers and food handlers with poor hygiene can all play ar role in contamination of 
vegetables (Araújo et al., 2017; Eltai et al., 2018; Narvaez-Bravo et al., 2016; Rahube et al., 
2014, 2016; Schulz et al., 2016; Tan et al., 2014). Furthermore, antibiotic use can lead to the 
maintenance of resistant organisms within animals or the environment possibly leading to 
contamination of plant-based foods (Holman & Chénier, 2013; McEwen & Fedorka-Cray, 2002).  
 Meanwhile, resistance distribution via food can be more complex when it comes to 
import and export around the world. Exporting countries having a high prevalence of resistant 
organisms and poor hygiene practices are more likely to contaminate the foods. Following 
contamination, it is challenging to control the temperature during transit from different countries 
and within domestic distribution possibly allowing contaminant organisms to multiply (Allen et 
al., 2013; McKellar, LeBlanc, Lu, & Delaquis, 2012). The contaminant organisms may include 
the frequently reported foodborne bacteria such as E. coli, Salmonella spp. and Gram-positives 
such as S. aureus and Enterococcus spp. (Allen et al., 2013; Bae et al., 2016; Anja Müller et al., 
2016; Zurfluh et al., 2015).  
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Emerging multidrug resistance among Enterobacteriaceae are particularly problematic; 
broad spectrum β-lactamases including TEM, SHV and CTX-M, confer resistance to penicillins 
and cephalosporins (Kliebe et al., 1985; Sirot et al., 1987; Tal Jasper et al., 2015). CTX-M 
hydrolyzes an extended-spectrum of penicillins and 3rd generation cephalosporins and plasmid-
mediated AmpC β-lactamases (CMY-2) hydrolyze a broader spectrum of cephalosporins and 
cephamycins (Philippon et al., 2002; Tal Jasper et al., 2015). Moreover, carbapenemases (IMP, 
VIM, KPC, OXA-48, NDM) hydrolyze carbapenems which have a very wide range of antibiotic 
activity (Daikos et al., 2014; Doi & Paterson, 2015; Poirel et al., 2012; Qureshi et al., 2012; 
Tumbarello et al., 2012). Another emerging resistance from Enterobacteriaceae is by PMQR 
determinants conferring resistance to fluoroquinolones and aminoglycosides. The determinants 
produce Qnr proteins that bind to holoenzyme and subunits of DNA gyrase and topoisomerase to 
protect them from quinolones. QepA is another example of PMQR determinants. QepA is an 
efflux pump conferring resistance to fluoroquinolones (Jacoby et al., 2014). Another PMQR 
determinant, AAC(6’)-Ib, is able to inactivate the aminoglycosides and fluoroquinolones by 
acetylation (Jacoby et al., 2014).  
Multi-drug resistant S. aureus and Enterococcus spp. also pose important therapeutic 
challenges. Methicillin resistant S. aureus (MRSA) produces PBP2a, an altered penicillin binding 
protein which confers resistance to all β-lactams (Hartman & Tomasz, 1981). Methicillin 
resistance of S. aureus is conferred by mecA and mecC genes among other mec family genes 
(mecB, mecD) identified from Macrococcus spp. (Baba et al., 2009; Katayama et al., 2000; 
Paterson et al., 2014; Schwendener et al., 2017). The mecA and mecC genes are found within the 
staphylococcal chromosomal cassette (SCCmec). The SCCmec is mobilizable through the action 
of the ccr genes which facilitate excision and reintegrating of the mec genes into methicillin 
susceptible S. aureus (MSSA) (Hartman & Tomasz, 1981; Katayama et al., 2000; Paterson et al., 
2014). Vancomycin resistant Enterococci (VRE) is resistant to vancomycin by production of 
altered peptidoglycan cell wall precursor, D-alanine-D-alanine, which the drug originally binds to 
inhibit linking of peptidoglycan chains and cell wall synthesis (Miller et al., 2014). Resistance is 
conferred by VanA or VanB and their genes are able to transmit to the susceptible Enterococci 
via plasmids or transposons (Courvalin, 2006; Kristich et al., 2014).  
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 Antimicrobial resistant bacteria have been identified from food all around the world. 
These studies have shown that the foodborne bacteria carry resistance genes conferring resistance 
to the 3rd generation cephalosporins and fluoroquinolones, and penicillins in the case of S. aureus 
and Enterococcus spp. Among the resistance genes, CTX-M and CMY-2 genes are increasingly 
identified from food products. CTX-M type ESBL producing genes and CMY-2 β-lactamase 
producing gene were identified from E. coli isolated from imported meats in Germany (Müller et 
al., 2018). CTX-M type ESBLs were also identified from Enterobacteriaceae including E. coli, K. 
pneumoniae, Enterobacter spp. and Salmonella spp. from imported vegetables and seafood in 
Switzerland and the United States (Zurfluh et al., 2015 and Bae et al., 2016). Gram-positive 
organisms including MRSA were identified from imported meats in Germany and penicillin 
resistant E. faecium were identified from imported vegetables in Canada (Müller et al., 2016 and 
Allen et al., 2013).   
Despite the research studies showing AMR in imported food and its transmission to 
countries having low prevalence of resistance, surveillance programs on foodborne resistant 
organisms around the world focus on meats available to consumers rather than specifically 
targeting imported foods. The National Antimicrobial Resistance Monitoring System (NARMS) 
from the United States and European Food Safety Authority (EFSA) have targeted domestic 
meats but not imported foods (Centers for Disease Control and Prevention, 2017; European Food 
Safety Authority & European Centre for Disease Prevention and Control, 2018). In Canada, 
CIPARS is the main surveillance program for identifying resistant bacteria from foods. However, 
the program has a couple of limitations. One is that only E. coli, Salmonella spp. and 
Campylobacter spp. are included. There are many other bacteria that potentially contaminate 
meat. For example, S. aureus, and C. difficile have been identified from food animals and meat 
products by researchers in Canada. MRSA has been identified from slaughtered pigs and retail 
pork from abattoirs (Narvaez-Bravo et al., 2016). Levofloxacin and clindamycin resistant C. 
difficile has been identified from ground meat products in Ontario and Quebec (Rodriguez-
Palacios et al., 2007). The other limitation of CIPARS is that it only focuses on particular 
categories of retail products; Canada imports a variety of foods including dairy products, fish and 
seafood and fresh or processed fruits/vegetables which are not included in routine surveillance 
(Canadian Food Inspection Agency, 2018). However, between 2011 and 2015, researchers 
launched projects off of the CIPARS infrastructure and studied imported dried spices and retail 
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seafoods and found resistant Enterobacteriaceae (Public Health Agency of Canada, 2018a). As a 
result, NDM, IMI type genes within E. cloacae and E. aerogenes have been identified from 
imported seafood and the VCC-1 gene from V. cholerae has been identified from imported 
shrimp (Janecko et al., 2016; Mangat et al., 2016; Public Health Agency of Canada, 2018a). 
Targeting more imported food and bacterial organisms are necessary as independent research 
studies have indicated; Morrison and Rubin have found carbapenemase producing Pseudomonas, 
Stenotrophomonas and Myroides spp. from imported seafoods (Morrison & Rubin, 2015). Allen 
et al. as another example, has found resistant E. faecalis and E. faecium from imported herbs, 
leafy greens and spinach from Columbia, Dominican Republic, Mexico, Guatemala and the US 
(Allen et al., 2013). Considering the findings from independent research studies, more different 
types of food and different bacteria have to be targeted for AMR identification in Canada. 
The identification of antibiotic resistant organisms from imported food in Canada is 
necessary to fill the gap on the antibiotic resistance transmission in Canada. Especially, imported 
vegetables and spices have been neglected by the national surveillance program and to a lesser 
extent research studies. In this study, antibiotic resistant organisms have been identified from 
imported vegetables and spices purchased from local international markets. Characterization of 
their resistance and species identification followed. This pilot investigation therefore provides 
fundamental information on transferability of antibiotic resistant organisms via neglected food 
sources in Canada.  
 
 
3.2. Method and Materials 
3.2.1. Food samples for bacteria isolation 
The ten international markets selling imported foods identified in Saskatoon, 
Saskatchewan were visited, and a convenience sampling of 147 vegetable and spice products 
were purchased (Figure 3.4). Although samples were selected conveniently, they were chosen to 
represent the breadth of products available. The samples were imported from 17 countries 
including Asian countries, India (n=34), China (n=20), Philippines (n=18), Thailand (n=24), 
Bangladesh (n=8), Vietnam (n=8), Sri Lanka (n=2), Taiwan (n=1) and Pakistan (n=1), African 
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countries, Cameroon (n=10), Congo (n=6), Togo (n=5), Ghana (n=4), Nigeria (n=4) and Egypt 
(n=1), and Jamaica (n=1). The samples consist of 77 different types and all samples were either 
frozen or dried when they were purchased. All samples were stored on the day of purchase; 
frozen samples were stored at -80℃ and dried samples were stored at room temperature.  
 
3.2.2. Bacteria isolation 
All frozen samples were completely thawed and prepared at room temperature before the 
bacteria isolation process. For isolation of the targeted bacterial organisms, washing of 25 grams 
of each sample, or the whole sample if ≤25g was available, in a sterile plastic bag with 250 mL of 
buffer peptone waterF (BPW) was conducted. After 5 minutes of washing, 50 mL of BPW were 
aliquoted into an empty sterile bottle and each double strength of selective broth, MacConkey 
brothH, modified tryptone broth (10 g/L of tryptone, 75 g/L of sodium chloride, 10 g/L of 
mannitol and 2.5 g/L of yeast) (Ji, 2007) and Enterococcosel brothF. All aliquoted broth and 
bottles were incubated at 35℃ for 20 hours.  
After the incubation, 10µL of MacConkey broth, modified tryptone broth and 
Enterococcosel broth was inoculated into eosin methylene blue agarI, mannitol salt agarF and 
Enterococcosel agarF respectively (Figure 3.4). Other selective agar plates, CHROMagar ESBLG 
and agar selective for meropenem resistant Gram-negatives (Mueller-Hinton agarF with 2µg/ml 
of meropenemA), and other additional selective broth, 10 mL of Rappaport-Vassiliadis (RV) 
brothF and tetrathionate brothF, were inoculated with 0.1 mL and 1 mL of incubated BPW 
respectively. All inoculated selective agar plates and tetrathionate broth were incubated at 35℃ 
for 20 hours, and incubated RV broth were incubated at 42℃ for 20 hours (Figure 3.4).  
On the following day, colonies were picked from each selective plate and streaked onto 
Columbia blood agar with 5% sheep bloodI. 10µL of RV and tetrathionate broth was inoculated 
into xylose lysine deoxycholoate (XLD) agarF and brilliant green (BG) agarF. All inoculated 
blood agar, XLD agar and BG agar were incubated at 35℃ for 20 hours. If colonies with targeted 
morphology from XLD agar and BG agar appeared on next day, the colonies were streaked into 
blood agar and incubated at 35℃ for 20 hours.  
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If blood agar contained the colonies with single morphology on the next day, colonies 
were streaked and inoculated into the cryogenic vile which contained 1mL of tryptic soy brothF 
with 15% of glycerol followed by storage in -80℃.  
To confirm the isolates from selective media were targeted organisms, biochemical tests 
were conducted (Table 3.2). IndoleJ and citrateJ tests were done for E. coli identification. Triple 
Sugar Iron (TSI)J and ureaM tests were done for Salmonella spp. identification. CHROMagar 
ESBL isolates were tested with DrySlide Oxidase test kitJ to distinguish Enterobacteriaceae from 
others. Coagulase test by BBL Coagulase Plasma, Rabbit with EDTAJ was done for the 
Staphylococcus spp. from mannitol salt agar plates and only coagulase positive isolates were 
included for further processing. Pyrrolidonyl arylamidase (PYR) testL was done for isolates from 
Enterococcosel agar plates to distinguish Enterococcus spp.  
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3.2.3. Species identification 
Polymerase chain reaction (PCR) with universal primers (Table 3. 3), targeting cpn60 or 
16s rRNA, was conducted to identify species of the isolates. Crude DNA extracts from isolates 
were obtained by boil prep. The reactions were conducted with 24 µL of master-mix (distilled 
water, 10X PCR buffer, dNTPs, primers, 50 mM Magnesium Chloride (MgCl2), Taq 
polymerase)Q and 1 µL of DNA template. Conditions for amplification of 16s rRNA and cpn60 
genes by C1000 Touch Thermal CyclerO are described in Table 3.4. Amplicons were resolved by 
gel electrophoresis using 1% agarose gel at 100 volts for 30 minutes. The gels were visualized 
under UV light of Gel Doc XR+O to identify the presence of targeted amplicons. To sequence the 
amplicons, amplified either cpn60 or 16s rRNA genes of isolates were purified by the Illustra 
ExoProStar kitP and EZ-10 Spin Column PCR purification kitN. All purified DNA was quantified 
by Nanodrop 2000 spectrophotometerR. To sequence DNA with high quality, the absorbance 
ratio of UV light (260:280nm) of 1.8, and a 260:230 ratio of 2.0-2.2 were used. All prepared 
genes were sent to a commercial lab (Macrogen; Seoul, Rep. of Korea) for sequencing. 
Sequenced data were assembled and analyzed using Pregap4 and Gap4 software which are part of 
Staden Package. Contigs were then compared with reference sequences from with National 
Center for Biotechnology Information (NCBI) GenBank. 
(https://blast.ncbi.nlm.nih.gov/Blast.cgi) to identify species of the isolates (Figure 3.4).  
To identify serotype of Salmonella spp., Salmonella spp. isolates were submitted to 
National Microbiology Laboratory in Guelph, ON for serotyping. Because the reference data 
from NCBI BLAST for E. casseliflavus and E. gallinarum were ambiguous, sequenced data were 
compared to each other to identify the most robust species.  
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Table 3. 3. List of universal targets primers 
Genes Primer sequence (5’->3’) Size References 
Universal targets    
cpn60 CGCCAGGGTTTTCCCAGTCACGAC 700bp (Sahin, Gonzalez, 
Iizuka, & Hill, 2010) AGCGGATAACAATTTCACACAGGA 
16s rRNA GAGTTTGATCCTGGCTCAG 500bp (Dorsch & 
Stackebrandt, 1992) GWATTACCGCGGCKGCTG 
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Table 3. 4. Temperature conditions of PCR for 16s rRNA and cpn60 
PCR reaction 
process 
16s rRNA cpn60 
Initial 
Denaturation 
94°C for 3 mins 
 
68°C, 1 min 
72°C, 1 min 
(Cycles) 
Denaturation 
Annealing 
Extension 
(x30) 
94°C, 30 secs 
60°C, 1 min 
72°C, 1 min 
(x40) 
94°C, 30 secs 
60°C, 1 min 
72°C, 1 min 
Final 
Extension 
72°C for 10 mins 
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3.2.4. Antimicrobial susceptibility testing 
 Antimicrobial susceptibility testing was done by broth microdilution method using the 
Sensititre Automated Inoculation systemD. Two different plate formats were used: the 
CMV4AGNF plateE for Gram-negative bacteria which contains 14 drugs from 7 classes and 
GPALL1F plateE for Gram-positive bacteria which contains 21 drugs from 16 classes. Testing 
was done according to the manufacturer’s instructions. Isolates were sub-cultured on blood agar 
and incubated at 35℃ overnight. Then, colonies from the plate were suspended in 5mL of 
demineralized waterD until its density reached 0.5 McFarland. 30 μL of the suspended water was 
added to 11 mL of cation-adjusted Mueller-Hinton brothD. 50 μL of the inoculated broth was 
dispensed into each well of designated plates for either Gram-negative or -positive using the 
Sensititre auto-inoculator. All plates were inoculated at 35℃ for 18-22 hours while being sealed 
by adhesive film. Minimum inhibitory concentrations (MICs) of each antimicrobial were 
interpreted after incubation (Figure 3.4).  
Because polymyxin drugs were not included in the NARMS plates, colistin susceptibility 
testing was done by agar dilution method. Colistin sulfate saltB were dissolved in distilled water 
to make different concentrations at 20 mL. Mueller-Hinton agar mixture was boiled, cooled and 
aliquoted into 18 mL volumes in glass vials. 2 mL of each colistin solution were then inoculated 
into each 18 mL of Mueller-Hinton agar mixture to make final concentrations ranging from 0.032 
to 64 µg/mL. Each different concentration was poured into a plate and solidified. To inoculate the 
agar plates with isolates, subcultured bacterial colonies on blood agars were prepared and 
suspended into demineralized water to make 0.5 McFarland suspension. 600 μL of the suspended 
water were transferred into wells of Cathra replicatorC and then inoculum from each well was 
spotted onto each colistin selective agar plate by the replicator (Figure 3.4).   
To identify either susceptible or resistant to each drug and non- or intrinsic resistance, 
Clinical and Laboratory Standards Institute (CLSI) and European Committee on Antimicrobial 
Susceptibility Testing (EUCAST) guidelines were referred (Clinical and Laboratory Standards 
Institute, 2014; European Society of Clinical Microbiology and Infectious Diseases, 2016) 
(Figure 3.4). For quality control, S. aureus ATCC 29213 and E. coli ATCC 25922, E. faecalis 
ATCC 29212 and P. aeruginosa ATCC 275853 were used. If meropenem resistant isolates were 
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identified from Gram-negative isolates, β CARBA testK was done to identify the presence of 
carbapenemases (KPC, OXA-48, NDM, VIM, and IMP).  
 
3.2.5. Resistance genes identification 
Isolates determined to be phenotypically resistant were screened for resistance genes 
including ESBLs (CTX-M, TEM, SHV), plasmid mediated AmpC β-lactamase (CMY-2), 
carbapenemase (IMP, KPC, NDM, OXA-48, VIM), PMQR determinants (QnrA, QnrB, QnrS, 
QepA, AAC(6’)-Ib), MCR (MCR-1, MCR-2, MCR-3, MCR-4) genes and class I integrons. The 
primers used are described in Table 3.5. The details PCR reactions are described in Tables 3.6 -
3.11. PCR amplicons were visualized and prepared for sequencing as previously described. The 
identity of analyzed contigs were then determined by comparison with reference sequences from 
The Comprehensive Antibiotic Resistance Database (CARD; https://card.mcmaster.ca/) and 
Lahey database (https://www.lahey.org/Studies/). Antibiotic Resistance Gene-ANNOTation 
(ARG-ANNOT; http://en.mediterranee-infection.com/article.php?laref=283%26titre=arg-annot) 
reference sequences were also compared with the contigs if there were more than two genes with 
same bit-score and identity from CARD (Figure 3.4).  
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Table 3. 5. List of resistance genes primers 
Genes Primer sequence (5’->3’) Size References 
blaSHV TTATCTCCCTGTTAGCCACC 797bp (Arlet, Rouveau, & 
Philippon, 1997) GATTTGCTGATTTCGCTCGG 
CGGCCCTCACTCAAGGATG  
(blaSHV-F sequence primer) 
336bp (Patricia A. 
Bradford, 1999) 
GCGAGTAGTCCACCAGATCC  
(blaSHV-F sequence primer) 
This study 
CTGCTGCAGTGGATGGTG  
(blaSHV-R sequence primer) 
350bp This study 
ATTACCGACCGGCATCTCTC  
(blaSHV-R sequence primer) 
CGCCGGGTTATTCTTATTTGTCGC  
(blaSHV-UP sequence primer) 
1016bp (Perilli et al., 2002) 
TCTTTCCGATGCCGCCGCCAGTCA  
(blaSHV-LO sequence primer) 
blaTEM GCGGAACCCCTATTTG 964bp (Olesen, Hasman, 
& Møller 
Aarestrup, 2004) 
ACCAATGCTTAATCAGTGAG 
blaCTX-M-U ATGTGCAGYACCAGTAARGTKATGGC 593bp (Mulvey, Soule, 
Boyd, Demczuk, & 
Ahmed, 2003) 
TGGGTRAARTARGTSACCAGAAYCAGC
GG 
blaCTX-M-G1 GTTGTTAATTCGTCTCTTCC 900bp (Ghosh, 2017) 
AGTTTCCCCATTCCGTTTC 
TGGGTRAARTARGTSACCAGAAYCAGC
GG 
(Forward sequence primer) 
(Mulvey et al., 
2003) 
blaCTX-M-G2 ACTCAGAGCATTCGCCGCTCA 1000bp (Ghosh, 2017) 
TTATTGCATCAGAAACCGTG 
 
blaCTX-M-G8 CGCTTTGCCATGTGCAGCACC 307bp (Pitout, Hossain, & 
Hanson, 2004) GCTCAGTACGATCGAGCC 
blaCTX-M-G9 GACCGTATTGGGAGTTTGAG 600bp (Hammad, Ishida, 
& Shimamoto, 
2009) 
ATCTGATCCTTCAACTCAGC (Gonsalves, 2011) 
blaCMY-2 ATGCAACAACGACAATCC 1000bp (Kim, Kwon, Pai, 
Kim, & Cho, 1998) 
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TTGGCCAGCATGACGATG (D’Andrea et al., 
2006) 
blaIMP GAAGGCGTTTATGTTCATAC 587bp (Pitout et al., 2005) 
GTACGTTTCAAGAGTGATGC 
blaKPC TGTCACTGTATCGCCGTC 900bp (Yigit et al., 2001) 
CTCAGTGCTCTACAGAAAACC 
blaNDM-1 GCAGCTTGTCGGCCATGCGGGC 782bp (Peirano, Ahmed-
Bentley, 
Woodford, & 
Pitout, 2011) 
GGTCGCGAAGCTGAGCACCGCAT 
blaOXA-48 GCGTGGTTAAGGATGAACAC 438bp (Poirel, Walsh, 
Cuvillier, & 
Nordmann, 2011) 
CATCAAGTTCAACCCAACCG 
blaVIM GTTTGGTCGCATATCGCAAC 382bp (Pitout et al., 2005) 
AATGCGCAGCACCAGGATAG 
aac(6’)-Ib TTGCGATGCTCTATGAGTGGCTA 482bp (Park, Robicsek, 
Jacoby, Sahm, & 
Hooper, 2006) 
CTCGAATGCCTGGCGTGTTT 
qnrA ATTTCTCACGCCAGGATTTG 516bp (Robicsek, 
Strahilevitz, Sahm, 
Jacoby, & Hooper, 
2006) 
GATCGGCAAAGGTTAGGTCA 
qnrB GATCGTGAAAGCCAGAAAGG 469bp 
ACGATGCCTGGTAGTTGTCC 
qnrS ACGACATTCGTCAACTGCAA 417bp 
TAAATTGGCACCCTGTAGGC 
qepA GCAGGTCCAGCAGCGGGTAG 199bp (J.-H. Liu et al., 
2008) CTTCCTGCCCGAGTATCGTG 
mcr-1 CGGTCAGTCCGTTTGTTC 309bp (Y.-Y. Liu et al., 
2016) CTTGGTCGGTCTGTAGGG 
mcr-2 TGGTACAGCCCCTTTATT 1,617bp (Xavier et al., 
2016) GCTTGAGATTGGGTTATGA 
mcr-3 TTGGCACTGTATTTTGCATTT 542bp (Yin et al., 2017) 
TTAACGAAATTGGCTGGAACA 
mcr-4 ATTGGGATAGTCGCCTTTTT 487bp (Carattoli et al., 
2017) TTACAGCCAGAATCATTATCA 
Class I 
Integron  
GGCATCCAAGCAGCAAG Variable (Pellegrini et al., 
2009) AAAGCAGACTTGACCTGA 
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Table 3. 6. Temperature conditions of PCR for SHV and TEM genes 
 
PCR reaction 
process 
blaSHV blaTEM 
blaSHV-U blaSHV-F blaSHV-R blaSHV-UP, LO 
Initial 
Denaturation 
94°C for 6 mins 
(Cycles) 
Denaturation 
Annealing 
Extension 
(x35) 
94°C, 1 min 
68°C, 1 min 
72°C, 1 min 
(x30) 
94°C, 1 min 
61.5°C, 1 min 
72°C, 1 min 
(x30) 
94°C, 1 min 
51.5°C, 1 min 
72°C, 1 min 
(x30) 
94°C, 1 min 
68°C, 1 min 
72°C, 1 min 
(x30) 
94°C, 1 min 
54.7°C, 1 min 
72°C, 1 min 
Final 
Extension 
72°C for 10 mins 
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Table 3. 7. Temperature conditions of PCR for CTX-M and AmpC genes 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
PCR 
reaction 
process 
blaCTX-M blaAmpC 
blaCTX-M-U blaCTX-M-G1 blaCTX-M-G2 blaCTX-M-G8 blaCTX-M-G9 blaCMY-2 
Initial 
Denaturation 
94°C for 6 mins 
(Cycles) 
Denaturation 
Annealing 
Extension 
(x35) 
94°C, 1 min 
59.5°C, 
 1 min 
72°C, 1 min 
(x35) 
94°C, 1 min 
61°C, 1 min 
72°C, 1 min 
(x35) 
94°C, 1 min 
58.3 °C,  
1 min 
72°C, 1 min 
(x35) 
94°C, 1 min 
64°C, 1 min 
72°C, 1 min 
(x30) 
94°C, 1 min 
61°C, 1 min 
72°C, 1 min 
(x30) 
94°C, 1 min 
50°C, 1 min 
72°C, 1 min 
Final 
Extension 
72°C for 10 mins 
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Table 3. 8. Temperature conditions of PCR for carbapenemases genes 
PCR reaction 
process 
Carbapenemase genes 
blaIMP blaKPC blaNDM-1 blaOXA-48 blaVIM 
Initial 
Denaturation 
95°C for 5 mins 
(Cycles) 
Denaturation 
Annealing 
Extension 
(x35) 
95°C, 45 secs 
55.1°C, 45 secs 
72°C, 1 min 
(x35) 
95°C, 45 secs 
54.8°C, 45 secs 
   72°C, 1 min 
(x40) 
95°C, 45 secs 
58.3 °C, 45 secs 
   72°C, 1 min 
(x35) 
95°C, 45 secs 
54.5°C, 45 secs 
   72°C, 1 min 
(x35) 
95°C, 45 secs 
60.3°C, 45 secs 
72°C, 1 min 
Final Extension 72°C for 8 mins 
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Table 3. 9. Temperature conditions of PCR for PMQR determinants genes 
PCR reaction 
process 
PMQR determinant genes 
aac(6’)-Ib qnrA qnrB qnrS qepA 
Initial 
Denaturation 
94°C for 6 mins 94°C for 3 mins 
(Cycles) 
Denaturation 
Annealing 
Extension 
(x35) 
94°C, 1 min 
68°C, 1 min 
72°C, 1 min 
(x35) 
94°C, 1 min 
53.4°C, 1 min 
72°C, 1 min 
(x35) 
94°C, 1 min 
66.1°C, 1 min 
72°C, 1 min 
(x35) 
94°C, 30 secs 
51°C, 30 secs 
72°C, 30 secs 
(x35) 
94°C, 30 secs 
61°C, 30 secs 
72°C, 30 secs 
Final 
Extension 
72°C for 10 mins 
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Table 3. 10. Temperature conditions of PCR for MCR genes 
PCR reaction  
Process 
MCR genes 
mcr-1 mcr-2 mcr-3 mcr-4 
Initial 
Denaturation 
94°C for 6 mins 
(Cycles) 
Denaturation 
Annealing 
Extension 
(x35) 
94°C, 1 min 
56°C, 1 min 
72°C, 1 min 
(x30) 
95°C, 1 min 
50°C, 1 min 
72°C, 1 min 
Final Extension 72°C for 3 mins 72°C for 10 mins 
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Table 3. 11. Temperature conditions of PCR for class I integron 
PCR reaction process Class I integron 
Initial Denaturation 94°C for 5 mins 
(Cycles) 
Denaturation 
Annealing 
Extension 
                            (x30) 
94°C, 30 secs 
68.2°C, 1 min 
72°C, 2 min 
Final Extension 72°C for 10 mins 
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3.2.6. Multilocus sequence typing  
 Sequence types (STs) of MDR E. coli, K. pneumoniae and S. aureus isolates were 
determined by MLST using previously published schemes (Diancourt, Passet, Verhoef, Grimont, 
& Brisse, 2005; M. C. Enright, Day, Davies, Peacock, & Spratt, 2000; Ghosh, 2017; Wirth et al., 
2006) (Table 3. 12). Targeted genes for each MLST were amplified by PCR reactions. 7 locus 
(adk, fumC, gyrB, icd, mdh, purA, recA) from E. coli, 6 locus (gapA, infB, mdh, phoE, pgi, rpoB) 
from K. pneumoniae and 6 locus (arcC, aroE, glpF, gmk, tpi, pta) from S. aureus were targeted 
for MLST. Primers that were used and conditions for each PCR reactions are indicated in Tables 
3.13 – 3.15. Sequences were analysed using online MLST databased: 
https://enterobase.warwick.ac.uk/species/ecoli/allele_st_search for E. coli, 
http://bigsdb.pasteur.fr/klebsiella/ for K. pneumoniae and http://saureus.mlst.net/ for S. aureus.   
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Table 3. 12. List of primers used in MLST schemes 
Genes Primer sequence (5’->3’) Size References 
E. coli  
adk ATTCTGCTTGGCGCTCCGGG 536bp (Wirth et al., 2006) 
 CCGTCAACTTTCGCGTATTT 
fumC TCACAGGTCGCCAGCGCTTC 469bp 
GTACGCAGCGAAAAAGATTC 
gyrB TCGGCGACACGGATGACGGC 460bp 
ATCAGGCCTTCACGCGCATC 
icd ATGGAAAGTAAAGTAGTTGTTCCGGCACA 518bp 
GGACGCAGCAGGATCTGTT 
mdh ATGAAAGTCGCAGTCCTCGGCGCTGCTGGCG
G 
452bp 
TTAACGAACTCCTGCCCCAGAGCGATATCTT
TCTT 
purA CGCGCTGATGAAAGAGATGA 478bp 
CATACGGTAAGCCACGCAGA 
recA GTGCGTTTATCGATGCTGAA 510bp (Ghosh, 2017) 
TCTTTTACGCCCAGGTCAAC 
K. pneumoniae  
gapA TGAAATATGACTCCACTCACGG 501bp (Diancourt et al., 2005) 
 CTTCAGAAGCGGCTTTGATGGCTT 
infB CTCGCTGCTGGACTATATTCG 318bp 
CGCTTTCAGCTCAAGAACTTC 
ACTAAGGTTGCCTCCGGCGAAGC  
(Forward sequencing primer) 
 
mdh CCCAACTCGCTTCAGGTTCAG 477bp 
CCGTTTTTCCCCAGCAGCAG 
phoE ACCTACCGCAACACCGACTTCTTCGG 420bp 
TGATCAGAACTGGTAGGTGAT 
pgi GAGAAAAACCTGCCTGTACTGCTGGC 432bp 
CGCGCCACGCTTTATAGCGGTTAAT 
CTGCTGGCGCTGATCGGCAT 
(Forward sequencing primer) 
 
TTATAGCGGTTAATCAGGCCGT  
(Reverse sequencing primer) 
 
rpoB GGCGAAATGGCWGAGAACCA 501bp 
GAGTCTTCGAAGTTGTAACC 
S. aureus    
arcC TTGATTCACCAGCGCGTATTGTC 456bp (M. C. Enright et al., 
2000) AGGTATCTGCTTCAATCAGCG 
aroE ATCGGAAATCCTATTTCACATTC 456bp 
51 
 
GGTGTTGTATTAATAACGATATC 
glpF CTAGGAACTGCAATCTTAATCC  465bp 
TGGTAAAATCGCATGTCCAATTC 
gmk ATCGTTTTATCGGGACCATC 429bp 
TCATTAACTACAACGTAATCGTA 
tpi TCGTTCATTCTGAACGTCGTGAA 402bp 
TTTGCACCTTCTAACAATTGTAC 
pta GTTAAAATCGTATTACCTGAAGG 474bp 
GACCCTTTTGTTGAAAAGCTTAA 
yqiL CAGCATACAGGACACCTATTGGC 516bp 
CGTTGAGGAATCGATACTGGAAC 
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Table 3. 13. Temperature conditions of PCR for E. coli MLST genes 
PCR reaction adk fumC gyrB icd mdh purA recA 
Initial 
Denaturation 
94°C for 6 mins 
(Cycles) 
Denaturation 
Annealing 
Extension 
                                          (x30) 
94°C, 1 min 
54°C-60°C, 1 min 
72°C, 1 min 
Final 
Extension 
72°C for 10 mins 
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Table 3. 14. Temperature conditions of PCR for K. pneumoniae MLST genes 
PCR reaction rpoB gapA mdh pgi phoE infB tonB 
Initial 
Denaturation 
94°C for 5 mins 
(Cycles) 
Denaturation 
Annealing 
Extension 
                                    (x35) 
94°C, 30 secs 
50°C-55°C, 30 secs 
72°C, 30 secs 
Final 
Extension 
72°C for 10 mins 
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Table 3. 15. Temperature conditions of PCR for MRSA MLST genes 
PCR reaction arcC aroE glpF gmk pta tpi yqiL 
Initial 
Denaturation 
95°C for 5 mins 
(Cycles) 
Denaturation 
Annealing 
Extension 
                                     (x30) 
95°C, 1 min 
50°C-60°C, 1 min 
72°C, 1 min 
Final 
Extension 
72°C for 5 mins 
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3.3. Results 
3.3.1. Bacteria isolation and their species identification 
E. coli (n=15, 10.2%), Salmonella spp. (n=2, 1.4%), Enterobacter spp. (n=10, 6.8%), K. 
pneumoniae (n=2, 1.4%), Acinetobacter spp. (n=11, 7.5%), Pseudomonas spp. (n=10, 6.8%), S. 
aureus (n=7, 4.8%) and Enterococcus spp. (n=68, 46.3%) were isolated from 147 imported 
vegetables and spices (Table 3.16 & 3.17).  
Species of Salmonella spp. isolates were Salmonella enterica subsp. enterica serovar 
Redlands and unnamed Salmonella spp. (Salmonella I:4, 12:r:-). ST (Sequence Type) of CTX-M 
containing E. coli were ST189 and ST226. ST of CTX-M containing K. pneumoniae were ST101 
and ST261. ST of MRSA isolates were ST834 and unknown due to lack of one of the targeted 
genes for MLST (Table 3.18 - 3.20). 
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Table 3. 16. Information of all isolates 
Isolate 
number 
Name 
Country of 
origin 
Condition 
E. coli  
(non-ESBL 
producer) 
Salmonella 
spp.  
CHROMagar 
ESBL isolates 
Meropenem 
resistant 
 Gram-negatives 
S. aureus Enterococcus spp. 
DJ001 Curry leaves  India Dried - - - - - - 
DJ002 Cinnamon Sticks flat  India Dried - - - - - - 
DJ003 Sichuan peppercorns  China Dried - - - - - - 
DJ004 Five spice powder  China Dried - - -  - - - 
DJ005 Brown rice  India Dried - - - - - - 
DJ006 
Spicy lentil chunks 
(Punjabi Wadi)  
India Dried - - - - - - 
DJ007 Chaney root  Jamaica Dried - - - - - - 
DJ008 
Dried taro leaves 
(Dahon ng gabi)  
Philippines Dried - - - - - 
DJ008D 
 (E. hirae) 
DJ009 Calamansi fruit  Philippines Fresh - - - - - - 
DJ010 
Pentaclethra 
macrophyl UGBA  
Cameroon Frozen - - - - - - 
DJ011 
Legume vert ugu 
ugu/Green vegetable 
Nigeria  
Togo Frozen - - - - - 
DJ011D  
(E. faecalis) 
DJ012 Liquorice roots  Pakistan Dried - - - - - - 
DJ013 
Pan Glori Candy 
(Sucrerie)  
India Dried - - - - - - 
DJ014 
Pan Glori Candy 
(Sucrerie)  
India Dried - - - - - - 
DJ015 Calcutta pan  India Dried - - - - - - 
DJ016 Calcutta pan  India Dried - - - - - - 
DJ017 Kokum wet  India Dried - - - - - - 
DJ018 Chili whole kashmiri  India Dried - - 
DJ018F 
 (E. cloacae) 
- - - 
DJ019 Mint leaves India Dried - - - - - - 
DJ020 Mint leaves (Tit-bit)  India Dried - - - - - - 
DJ021 Coconut slice  India Dried - - - - - - 
DJ022 
Anardana whole 
(pomegranate seeds)  
India Dried - - - - - - 
DJ023 
Anardana whole 
(pomegranate seeds)  
India Dried - - - - - - 
DJ024 Noori (Alu Bukhara)  India Dried - - - - - - 
DJ025 Tulsi leaf  India Dried - - - - - 
DJ025D  
(E. gallinarum) 
DJ026 Tulsi leaf  India Dried - - - - - 
DJ026D  
(E. gallinarum) 
DJ027 Spice powder mix  China Dried - - - - - - 
DJ028 Spice powder mix  China Dried - - - - - - 
DJ029 
Dried hairy basil 
leaves  
Thailand Dried - - - - - - 
DJ030 
Dried hairy basil 
leaves  
Thailand Dried - - - - - - 
DJ031 
Dried hairy basil 
leaves  
Thailand Dried - - - - - - 
DJ032 Mbinzo  Congo Dried - - - - - 
DJ032D  
(E. gallinarum) 
DJ033 Mbinzo  Congo Dried - - - - - 
DJ033D  
(E. faecalis,  
 E. gallinarum) 
DJ034 Dilombo lombo  Congo Dried - - - - - - 
DJ035 Dilombo lombo  Congo Dried - - - - - - 
DJ036 Mayebo  Congo Dried - - - - - - 
DJ037 Mayebo  Congo Dried - - - - - - 
DJ038 
Soursop leaf-Fine cut 
leaf  
Sri Lanka Dried - - - - - - 
DJ039 
Soursop leaf-Fine cut 
leaf  
Sri Lanka Dried - - - - - - 
DJ040 Nchuonwu leaf  Ghana Dried - DJ040B 
DJ040F  
(A. baumannii) 
- - 
DJ040D  
(E. faecium, 
 E. hirae) 
DJ041 Nchuonwu leaf  Ghana Dried - - - - - 
DJ041D 
 (E. hirae) 
DJ042 Utazi leaf Ghana Dried - - 
DJ042F  
(A. baumannii) 
- - 
DJ042D 
 (E. gallinarum) 
DJ043 Utazi leaf  Ghana Dried - - DJ043F - - DJ043D  
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 (A. baumannii) (E. casseliflavus, 
E. hirae, 
 E. gallinarum)  
DJ044 Senna leaf India Dried - - - - - - 
DJ045 Senna leaf  India Dried - - - - - - 
DJ046 
Dried kaffir lime 
leaves  
Thailand Dried - - - - - - 
DJ047 
Dried kaffir lime 
leaves  
Thailand Dried - - - - - - 
DJ048 Ginger powder  China Dried - - - - - - 
DJ049 Five spice powder  Taiwan Dried - - - - - - 
DJ050 Five spice powder  China Dried - - - - - - 
DJ051 Ginger  China Dried - - - - - - 
DJ052 Ginger  China Dried - - - - - - 
DJ053 Seasoning powder  China Dried - - - - - - 
DJ054 Dried rose  China Dried - - - - - - 
DJ055 Frozen sadao flower  Bangkok Frozen - - - - - - 
DJ056 Frozen tumeric  Bangkok Frozen - - - - - - 
DJ057 Frozen turmeric  Bangkok Frozen DJ057A - - - - - 
DJ058 Lemon grass  Bangkok Frozen - - - - - - 
DJ059 Lemon grass  Bangkok Frozen - - - - - - 
DJ060 Frozen pandan leaves  Thailand Frozen - - - 
DJ060E  
(S. maltophilia) 
- 
DJ060D 
 (E. hirae) 
DJ061 Frozen sadao flower  Bangkok Frozen - - - - - - 
DJ062 Frozen pandan leaves  Bangkok Frozen DJ062A - - 
DJ062E  
(S. maltophilia) 
- 
DJ062D 
 (E. gallinarum) 
DJ063 
Seasonal vegetable  
(Kachur lati-mix 
stolon of taro)  
Bangladesh Frozen DJ063A - - 
DJ063E  
(S. maltophilia) 
- 
DJ063D 
 (E. faecalis, 
 E. hirae) 
DJ064 
Seasonal vegetable  
(Kachur lati-mix 
stolon of taro) 
Bangladesh Frozen - - 
DJ064F  
(E. cloacae) 
DJ064E  
(S. maltophilia) 
- 
DJ064D  
(E. faecalis) 
DJ065 Chopped molokhia Egypt Frozen - - 
DJ065F 
 (A. guillouiae) 
DJ065E  
(S. maltophilia) 
DJ065C  
DJ065D 
 (E. faecium) 
DJ066 
Seasonal vegetable  
(Seembichi-hyacinth 
bean seeds) 
Bangladesh Frozen DJ066A - 
DJ066F 
 (E. coli) 
DJ066E 
 (P. fulva, 
 P. putida) 
- 
DJ066D 
 (E. hirae) 
DJ067 
Baby bhindi (baby 
okra)  
India Frozen - - - 
DJ067E  
(S. maltophilia) 
- 
DJ067D  
(E. hirae) 
DJ068 Sheem bichi Bangladesh Frozen DJ068A - 
DJ068F 
 (E. coli) 
- - 
DJ068D 
 (E. hirae) 
DJ069 Karela (Bitter Gourd) India Frozen - - - - - - 
DJ070 
Seeds of flat bean 
(Lablab niger) 
Bangladesh Frozen DJ070A - - 
DJ070E  
(S. maltophilia) 
- 
DJ070D  
(E. faecium) 
DJ071 
Kochur loti (Clean 
taro stems) 
Bangladesh Frozen - - - 
DJ071E  
(P. fluorescens) 
- 
DJ071D  
(E. hirae) 
DJ072 Stem amaranth Bangladesh Frozen - - - - - - 
DJ073 Stem amaranth Bangladesh Frozen - - - - - - 
DJ074 Frozen kachai Thailand Frozen - - 
DJ074F 
 (E. cloacae) 
- - - 
DJ075 Horseradish leaves  Philippines Frozen - - - - - 
DJ075D  
(E. faecalis,  
E. faecium) 
DJ076 Frozen whole okras  Vietnam Frozen - - - - - 
DJ076D 
 (E. faecalis) 
DJ077 
Bittermelon leaves 
(Ampalaya) 
Philippines Frozen DJ077A - 
DJ077F  
(E. cloacae) 
DJ077E 
 (P. monteilii) 
- 
DJ077D  
(E. casseliflavus, 
E. hirae) 
DJ078 
Bittermelon leaves 
(Ampalaya)  
Philippines Frozen DJ078A - - 
DJ078E 
 (P. fulva) 
- 
DJ078D 
 (E. faecium) 
DJ079 Sweet potato leaves Philippines Frozen - - 
DJ079F  
(E. hormaechei) 
- DJ079C  
DJ079D  
(E. faecalis) 
DJ080 Pepper leaves  Philippines Frozen - - 
DJ080F  
(E. aerogenes) 
- DJ080C 
DJ080D  
(E. hirae) 
DJ081 Horseradish leaves  Philippines Frozen - - - - - - 
DJ082 Frozen kachai  Thailand Frozen - - - - - - 
DJ083 Frozen whole okras  Vietnam Frozen - - 
DJ083F  
(E. cloacae, 
 E. hormaechei) 
DJ083E  
(P. fluorescens, 
 S. maltophilia) 
-  
DJ083D 
 (E. faecalis) 
DJ084 Pepper leaves  Philippines Frozen - - - 
DJ084E 
 (P. parafulva) 
DJ084C  
DJ084D 
 (E. hirae) 
DJ085 Sweet potato leaves  Philippines Frozen - - - - DJ085C  - 
DJ086 Screwpine leaves  Philippines Frozen - - - - - 
DJ086D  
(E. hirae) 
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DJ087 Frozen whole tumeric  Vietnam Frozen - - - 
DJ087E 
 (P. putida) 
- - 
DJ088 
Frozen tomyum 
mixed  
Thailand Frozen - - - 
DJ088E  
(S. maltophilia) 
- - 
DJ089 Screwpine leaves Philippines Frozen - - - - - 
DJ089D  
(E. faecium,  
E. hirae) 
DJ090 
Frozen tomyum 
mixed 
Thailand Frozen - - - - - 
DJ090D  
(E. gallinarum) 
DJ091 Grated Purple yam  Philippines Frozen - - - 
DJ091E  
(S. maltophilia) 
- 
DJ091D 
 (E. faecalis) 
DJ092 Squash flower  Philippines Frozen - - - 
DJ092E 
 (S. maltophilia) 
- 
DJ092D  
(E. casseliflavus, 
E. gallinarum) 
DJ093 Squash flower  Philippines Frozen - - 
DJ093F 
 (A. baumannii, 
 A. pittii) 
DJ093E  
(P. putida) 
- 
DJ093D 
 (E. gallinarum) 
DJ094 Grated Purple yam  Philippines Frozen - - - 
DJ094E 
 (S. maltophilia) 
DJ094C 
DJ094D 
 (E. faecalis) 
DJ095 Palm heart  Philippines Frozen - - - - - - 
DJ096 Palm heart  Philippines Frozen - - - - - - 
DJ097 Whole tumeric  Vietnam Frozen - - - 
DJ097E 
 (S. maltophilia) 
- - 
DJ098 Frozen tamarind fruit Vietnam Frozen - - - - - - 
DJ099 Frozen Sa-tor  Thailand Frozen - - - - - - 
DJ100 Frozen Sa-tor  Thailand Frozen - - - - - - 
DJ101 
Cooked frozen 
bamboo shoots  
China Frozen - - - - - 
DJ101D 
 (E. gallinarum) 
DJ102 
Frozen steamed 
sliced banana  
Vietnam Frozen - - - - - - 
DJ103 Frozen mixed chili  Thailand Frozen - - - - - 
DJ103D  
(E. faecalis) 
DJ104 Frozen mixed chili  Thailand Frozen - - - - - - 
DJ105 Frozen tamarind fruit  Vietnam Frozen - - - - - - 
DJ106 Frozen Cha-om  Thailand Frozen - - - 
DJ106E  
(S. maltophilia) 
- 
DJ106D 
 (E. faecalis) 
DJ107 Salted seaweed slice  China Dried - - - - - - 
DJ108 Salted seaweed slice  China Dried - - - - - - 
DJ109 Wolfberry lycium  China Dried - - - - - 
DJ109D 
 (E. mundtii) 
DJ110 Wolfberry lycium  China Dried - - - - - 
DJ110D  
(E. mundtii) 
DJ111 Organic Goji berry  China Dried - - - - - - 
DJ112 Organic Goji berry  China Dried - - - - - - 
DJ113 Tumeric whole  India Dried - - 
DJ113F 
 (E. cloacae) 
- - - 
DJ114 Tumeric whole  India Dried - - - - - - 
DJ115 
Chili whole regular 
(with stem)  
India Dried - - - - - - 
DJ116 Sounth (dry ginger)  India Dried - - - - - - 
DJ117 Ugu leaves  Togo Frozen - - - - - 
DJ117D  
(E. faecalis, 
 E. hirae) 
DJ118 Ugu leaves  Togo Frozen - - - - - 
DJ118D  
(E. faecium, 
 E. hirae) 
DJ119 Okra (Bhindi)  Cameroon Frozen - - 
DJ119F  
(A. baumannii) 
DJ119E 
 (P. reactans) 
- 
DJ119D  
(E. faecalis) 
DJ120 Okra (Bhindi)  Cameroon Frozen - - 
DJ120F  
(A. baumannii) 
- - 
DJ120D  
(E. faecalis, 
 E. hirae) 
DJ121 Ukazi  Cameroon Frozen - - - - - 
DJ121D  
(E. faecalis) 
DJ122 Ukazi  Cameroon Frozen - - - - - 
DJ122D 
 (E. faecalis, 
 E. hirae) 
DJ123 Gboma  Togo Frozen - - - - - 
DJ123D  
(E. faecium) 
DJ124 Gboma  Togo Frozen - - - 
DJ124E 
 (S. maltophilia) 
- 
DJ124D  
(E. faecium) 
DJ125 Jute leaves Cameroon Frozen - - - - DJ125C 
DJ125D 
 (E. faecalis) 
DJ126 Jute leaves  Cameroon Frozen - - - 
DJ126E 
 (A. baumannii) 
- 
DJ126D  
(E. faecalis, 
 E. gallinarum) 
DJ127 
Frozen bamboo 
shoots  
China Frozen - - - 
DJ127E 
 (A. baumannii) 
- 
DJ127D 
 (E. gallinarum) 
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DJ128 Frozen Cha-om  Thailand Frozen - - - - - 
DJ128D 
 (E. faecalis, 
 E. hirae) 
DJ129 
Punjabi tinda (Indian 
baby pumpkin slices)  
India Frozen - - - - - 
DJ129D  
(E. faecalis,  
E. mundtii) 
DJ130 Sambhar mix  India Frozen - - 
DJ130F 
 (K. pneumoniae) 
- - DJ130D (E. hirae) 
DJ131 Sambhar mix  India Frozen - - - - - 
DJ131D 
 (E. gallinarum) 
DJ132 
Punjabi tinda (Indian 
baby pumpkin slices)  
India Frozen - - - 
DJ132E 
 (A. baumannii, 
 S. maltophilia) 
- 
DJ132D  
(E. faecium, 
 E. mundtii) 
DJ133 Surti unduiu mix  India Frozen - - - - - 
DJ133D 
 (E. faecalis,  
E. thailandicus) 
DJ134 Surti unduiu mix  India Frozen - - - - - 
DJ134D 
 (E. gallinarum) 
DJ135 Fenu greek  India Frozen DJ135A - - - - 
DJ135D  
(E. faecalis) 
DJ136 Fenu greek  India Frozen DJ136A - - - - 
DJ136D  
(E. faecalis,  
E. gallinarum) 
DJ137 
Frozen steamed 
sliced banana  
Vietnam Frozen - - 
DJ137F 
 (E. hormaechei)  
- - - 
DJ138 Frozen rhizome  Thailand Frozen - - - - - - 
DJ139 Solanum melangina  Cameroon Frozen DJ139A - - - - 
DJ139D  
(E. faecalis, E. 
hirae, E. mundtii) 
DJ140 Solanum melangina  Cameroon Frozen - - - - - 
DJ140D  
(E. hirae) 
DJ141 Cassava leaves  Cameroon Frozen - - - - - - 
DJ142 Chopped spinach  China Frozen DJ142A - 
DJ142F 
 (E. aerogenes) 
- - 
DJ142D  
(E. hirae) 
DJ143 Chopped spinach  China Frozen - - 
DJ143F  
(K. pneumoniae) 
- - 
DJ143D  
(E. hirae) 
DJ144 Peppers  Nigeria Frozen - - - - - 
DJ144D  
(E. hirae) 
DJ145 Peppers  Nigeria Frozen - - - 
DJ145E  
(P. monteilii) 
- 
DJ145D  
(E. casseliflavus, 
E. faecalis) 
DJ146 Ukazi  Cameroon Frozen - DJ146B - - - 
DJ146D 
 (E. casseliflavus, 
E. faecalis, 
 E. hirae)  
DJ147 Ukazi  Cameroon Frozen DJ147A - 
DJ147F 
 (A. baumannii) 
- - 
DJ147D 
 (E. faecalis, 
 E. hirae) 
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Table 3. 17. Summary of isolated bacteria 
Organism Number (%) of 
samples (n=147) 
Species/serotype Number (%) of 
samples (n=147) 
Escherichia coli 15 (10.2%)   
Salmonella spp. 2 (1.4%) Unnamed serotype (Salmonella I:4, 12:r:-) 1 (0.7%) 
 S. enterica subsp. enterica Redlands 1 (0.7%) 
Enterobacter spp. 10 (6.8%) E. cloacae 6 (4.1%) 
 E. aerogenes 2 (1.4%) 
 E. hormaechei 3 (2.1%) 
Klebsiella pneumoniae 2 (1.4%)   
Acinetobacter spp. 11 (7.5%) A. baumannii 10 (6.8%) 
 A. guillouiae 1 (0.7%) 
 A. pittii 1 (0.7%) 
Pseudomonas spp. 10 (6.8%) P. fulva 3 (2.1%) 
 P. fluorescens 2 (1.4%) 
 P. monteilii 2 (1.4%) 
 P. parafulva 1 (0.7%) 
 P. putida 3 (2.1%) 
 P. reactans 1 (0.7%) 
Stenotrophomonas 
maltophilia 
16 (10.9%)   
Staphylococcus aureus 7 (4.8%)   
Enterococcus spp. 68 (46.3%) E. faecalis 28 (19.0%) 
 E. faecium 10 (6.8%) 
 E. hirae 28 (19.0%) 
 E. gallinarum 16 (10.9%) 
 E. casseliflavus 5 (3.4%) 
 E. mundtii 5 (3.4%) 
 E. thailandicus 1 (0.7%) 
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Table 3. 18. MLST profile of E. coli isolates 
 ST Allele of housekeeping genes 
adk fumC gyrB icd mdh purA recA 
DJ066F ST189 10 27 5 10 12 8 49 
DJ084C ST226 10 27 5 8 8 7 2 
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Table 3. 19. MLST profile of K. pneumoniae isolates 
 ST Allele of housekeeping genes 
infB mdh pgi phoE rpoB tonB gapA 
DJ130F ST101 6 1 5 4 1 6 2 
DJ084C ST261 1 1 1 4 27 12 2 
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Table 3. 20. MLST profile of MRSA isolates 
 ST Allele of housekeeping genes 
arcC aroE glpF gmk pta tpi yqiL 
DJ079C Unidentified 151 - 215 34 175 180 169 
DJ084C ST834 3 124 1 1 1 1 40 
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3.3.2. Phenotypic resistance of isolates 
MDR E. coli, Enterobacter spp., K. pneumoniae, Acinetobacter spp. and Pseudomonas 
spp. were identified (Table 3.21). Among E. coli isolates, ampicillin, nalidixic acid, 
trimethoprim/sulfamethoxazole, sulfisoxazole, tetracycline and gentamicin resistant E. coli were 
isolated from one sample. Two samples had ampicillin, ceftriaxone and sulfisoxazole resistant E. 
coli isolates. Among Enterobacter spp. isolates, ceftriaxone, nalidixic acid, ciprofloxacin, 
trimethoprim/sulfamethoxazole, sulfisoxazole, tetracycline and chloramphenicol resistant E. 
cloacae were isolated from two samples. One of the samples also had E. aerogenes also resistant 
to ceftriaxone, nalidixic acid, ciprofloxacin, trimethoprim/sulfamethoxazole, sulfisoxazole, 
tetracycline and chloramphenicol. K. pneumoniae were isolated from two samples; the isolate 
from one sample was resistant to ceftriaxone, trimethoprim/sulfamethoxazole and sulfisoxazole 
and the other isolate from other sample were resistant to ceftriaxone, 
trimethoprim/sulfamethoxazole, sulfisoxazole, tetracycline and gentamicin. Among 
Acinetobacter spp. isolates, A. baumannii isolate from one sample was resistant to meropenem, 
ciprofloxacin, gentamicin, sulfisoxazole and colistin and the isolates from two samples were 
resistant to meropenem, ciprofloxacin, gentamicin and colistin. Another species of isolate, A. 
guillouiae, from one sample was resistant to meropenem and gentamicin.  
Among the S. aureus isolates, penicillin resistant strains were isolated from six samples 
including two which contained MRSA. All other S. aureus were susceptible to all drugs tested. 
Phenotypic resistance of Enterococcus spp. isolates is indicated in Table 3.22. Chloramphenicol, 
rifampin, tetracycline, ciprofloxacin and levofloxacin resistance were identified from E. faecalis 
isolates. Rifampin, quinupristin/dalfopristin, ciprofloxacin, levofloxacin and nitrofurantoin 
resistance were identified from E. faecium isolates. Chloramphenicol, rifampin, 
quinupristin/dalfopristin, tetracycline and nitrofurantoin resistance were identified from E. hirae 
isolates. Rifampin, tetracycline, ciprofloxacin and levofloxacin resistance were identified from E. 
gallinarum isolates. Quinupristin/dalfopristin and tetracycline resistance were identified from E. 
casseliflavus isolates. However, resistance of Enterococcus spp. isolates to ampicillin, penicillin 
and vancomycin was not identified.   
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3.3.3. Resistance gene identification  
Identified resistance genes from resistant Gram-negative organisms are listed in Table 
3.20. Among broad spectrum β-lactamase genes, TEM (1.4%), SHV (1.4%) and CTX-M (4.8%) 
genes were identified, no carbapenemase genes were found. qnrB (1.4%), qnrS (0.7%), aac(6’)-
Ib-cr (2.0%) among PMQR determinants genes, and class I integrons which harboured dfrA 
(0.7%) and aad (0.7%) genes were identified.  
Among penicillin and oxacillin resistant S. aureus isolates, mecA gene from oxacillin 
resistant S. aureus isolates from two different samples was identified confirming MRSA. 
 
 
3.4. Discussion 
In this study, antimicrobial resistant organisms were identified from 147 imported vegetables 
and spices and their resistance was characterized.  
All foods having E. coli were frozen and all of the samples were plant-based vegetables. 
Among other samples, three samples from Asia had E. coli which harboured mobile resistance 
genes; dfrA12, blaTEM-1 and blaCTX-M-15. Two bean type samples imported from Bangladesh had 
ESBL producing E. coli isolates. The isolates from both samples harboured blaTEM-1 and blaCTX-
M-15 and all were resistant to ampicillin and ceftriaxone along with sulfisoxazole. These isolates 
were ST189 and ST226. Interestingly, ST189 has been reported to be isolated from poultry and 
associated with ESBL/plasmid mediated AmpC β-lactamases; German isolates producing CTX-
M-1 and Columbian isolates producing SHV-5/CMY-2 have been previously reported (Belmar 
Campos et al., 2014; Castellanos et al., 2017; Hussein et al., 2013; Solà-Ginés et al., 2015). 
(Belmar Campos et al., 2014; Castellanos et al., 2017). ST226 has been reported to be isolated 
from human patients, broiler chickens and wild boars and associated with ESBL; Chinese isolates 
producing CTX-M-65, and Nigerian and Algerian isolates producing CTX-M-15 have been 
reported. (Bachiri et al., 2017; Chah et al., 2018; Chen et al., 2014). Considering distribution of 
this sequence type in human, food animal and wildlife animal, contamination from human or 
wildlife to the bean products from this study may have occurred. Furthermore, to the best of our 
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knowledge, that these sequence types of E. coli harbouring ESBL can be transferred across the 
continents is a new finding.  
An E. coli resistant to trimethoprim/sulfamethoxazole and sulfisoxazole along with 
gentamicin, nalidixic acid, sulfisoxazole and ampicillin from a chopped spinach product imported 
from China harboured dfrA12 in a class I integron. Disinfectant resistance has also previously 
been shown to be conferred by qacEΔ1 originally conserved in class I integron indicating 
possible dissemination of another type of resistance (Gillings, 2014).  
Salmonella spp. isolates were identified from two leaf-type samples imported from Ghana 
and Cameroon respectively. Among Enterobacteriaceae isolates, Salmonella spp. is tolerant of 
low-moisture which might be the reason for the Salmonella spp. isolate to have survived in the 
dried Ghanaian leaves product. (Mattick, Jørgensen, Legan, Lappin-Scott, & Humphrey, 2000). 
Its serotype is unnamed, however characterization by another technique such as whole genome 
sequencing might be possible. The other Salmonella spp. isolate, which is Salmonella Redlands, 
from a Cameroonian product has been reported from at least one human infection and the 
environment (surface water and reptiles) (Cherry et al., 1972; Dondero, Thomas, Khare, 
Timoney, & Fukui, 1977; Lapage, Taylor, Nicewonger, & Phillips, 1966; Riemann & Cliver, 
2006).  
K. pneumoniae isolates were isolated from Sambhar mix (vegetable mix including tomatoes, 
Indian vegetable drumstick, eggplant, onion, okra, bottle gourd, green chillies and curry leaves) 
and chopped spinach imported from India and China respectively. The isolate from Sambhar mix 
harboured blaCTX-M-15 and blaSHV-106 and was resistant to ceftriaxone, 
trimethoprim/sulfamethoxazole and sulfisoxazole. This K. pneumoniae isolate was ST101, a 
strain frequently identified with human infections in Asia (Lee et al., 2012; Low et al., 2017; Ma, 
Lu, Siu, & Hsieh, 2013; Yu et al., 2017). Previous studies reported K. pneumoniae ST101 
producing ESBLs and other types of broad spectrum β-lactamases (narrow spectrum β-
lactamases, ESBL, plasmid mediated AmpC β-lactamases, carbapenemases). However, there is 
no study reporting this sequence type from any types of food or environmental settings. The 
isolate from Chinese chopped spinach harboured blaCTX-M-14 and blaSHV-142 and was resistant to 
ceftriaxone, trimethoprim/sulfamethoxazole, sulfisoxazole, tetracycline and gentamicin. This 
isolate was ST261 and it has been rarely identified from Asia. Only one study from South Korea 
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identified CTX-M-14 producing K. pneumoniae ST261 from a human infection (Ko et al., 2010). 
To our best knowledge, this strain only has been identified in meat products (Eibach et al., 2018). 
ESBL producing K. pneumoniae ST261 was identified from locally produced meats in Ghana 
(Eibach et al., 2018). However, ST261 has not been identified from imported food. Therefore, 
these MDR K. pneumoniae isolates from imported sambhar mix and chopped spinach indicate 
imported vegetables as a novel route of resistance transmission across the continents.  
Enterobacter spp. isolates were identified from stolon of taro and chopped spinach imported 
from Bangladesh and China respectively. Enterobacter spp. isolates harboured more mobile 
resistance genes (ESBL, PMQR determinants and class I integron) than the rest of 
Enterobacteriaceae isolates did. E. cloacae was isolated from stolon of taro and harboured blaCTX-
M-15, blaTEM-1, qnrB1, aac(6’)-Ib-cr and class I integron with aadA1. These resistance genes may 
explain the phenotypic resistance including ceftriaxone, nalidixic acid, ciprofloxacin, 
trimethoprim/sulfamethoxazole and sulfisoxazole. The other sample, chopped spinach, had E. 
cloacae and E. aerogenes; E. cloacae isolate harboured blaCTX-M-27, qnrB2, qnrS1 and aac(6’)-Ib-
cr, and E. aerogenes isolate harboured blaCTX-M-27 and aac(6’)-Ib-cr. Interestingly, although the 
E. aerogenes was fluoroquinolone resistant, no PMQR genes were identified. All Enterobacter 
spp. isolates were resistant to ampicillin, amoxicillin/clavulanic acid, cefoxitin and ceftriaxone 
which plasmid mediated AmpC β-lactamase was expected. However, none of Enterobacter spp. 
isolates had blaCMY-2. A previous Dutch study identified 3
rd generation cephalosporin and 
quinolone resistant Enterobacter spp. isolates from culinary herbs imported from Southeast Asia 
(Veldman et al., 2014). E. cloacae complex isolates from holy basil and parsley from Malaysia 
and Vietnam respectively and Enterobacter spp. isolate from houttuynia leaf from Vietnam were 
identified (Veldman et al., 2014). Their Enterobacter spp. isolates harboured broad spectrum β-
lactamase genes (blaTEM-1 blaTEM-1b blaOXA-1, blaCTX-M-40, blaCTX-M-15) and PMQR genes (qnrS1, 
qnrB1, qnrB26, aac(6’)-Ib-cr). The findings by Veldman et al. and this study suggest more clear 
evidence of the transfer of resistant Enterobacteriaceae via food from Asia to different continents.   
All meropenem resistant isolates were A. baumannii, A. guillouiae, P. fluorescens, P. 
monteilii and P. putida. Interestingly, none of the isolates harboured any carbapenemase 
producing genes, blaNDM, blaVIM, blaIMP, blaKPC and blaOXA-48 and all were negative for 
carbapenemase production by the β-carba test. Furthermore, although isolates of P. fluorescens 
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(n=2) and A. baumannii isolates (n=2) were colistin resistant, no mobile colistin resistance genes, 
mcr-1, mcr-2, mcr-3 and mcr-4, were identified. Their meropenem and colistin resistance may be 
due to mutated outer membrane proteins (OMPs), upregulated efflux pump systems and/or 
lipopolysaccharide change (Chalhoub et al., 2016; Clausell et al., 2007; Estepa, Rojo-Bezares, 
Torres, & Sáenz, 2015; Fernández-Cuenca et al., 2003; Hawkey et al., 2018; Huang, Sun, Xu, & 
Xia, 2008; Moffatt et al., 2010; Moskowitz et al., 2012; Mussi, Limansky, & Viale, 2005; Rojo-
Bezares et al., 2014). However, unlike carbapenemase and MCR, all these resistance mechanisms 
are only identified from Acinetobacter spp. and Pseudomonas spp. and do not contribute to 
acquired resistance of carbapenem and polymyxin. Therefore, the findings from Acinetobacter 
spp. and Pseudomonas spp. are less significant when it comes to resistance distribution. 
There were MRSA isolates from two samples, sweet potato leaves (DJ079C) and pepper 
leaves (DJ084C), both imported from Philippines. The closest STs of DJ079C were identified 
with six housekeeping genes with single variant gene (aroE): ST1667, ST2196, ST2483 and 
ST2250 (Enright, 2018).  DJ084C was assigned to ST834. The first identified ST834 from 
Australia in 2006 was also MRSA according to the MLST database (M. Enright, 2018). Since 
then, all identified ST834 isolates in Norway, Saudi Arabia and Kuwait were also MRSA 
(Monecke, Aamot, Stieber, Ruppelt, & Ehricht, 2014; Monecke et al., 2012; Udo & Sarkhoo, 
2010). These results indicate that ST834 is globally distributed. One of these studies indicated 
that their identified MRSA ST834 was from patients with a history of travel to the Philippines 
(Monecke et al., 2014). Although the finding by Monecke et al. might be an indicator, this 
investigation was designed to identify resistant organisms rather than determining the country of 
origin of this strain. Furthermore, similar to Enterobacteriaceae isolates, all MRSA isolates may 
have originated from human as all were STs which were previously reported to have been 
isolated from human patients.  
Enterococcus spp. was isolated from more samples than the other genera. There were MDR 
Enterococcus spp. isolates, including ciprofloxacin, nitrofurantoin, tetracycline, 
quinupristin/dalfopristin and chloramphenicol. However, none of them were resistant to penicillin 
or vancomycin. Quinupristin/dalfopristin are streptogramins for alternative treatment of VRE 
infection. VatD, transposon mediated acetyltransferase, is known to confer streptogramin A 
resistance (Rende-Fournier, Leclercq, Galimand, Duval, & Courvalin, 1993). Macrolide, 
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lincosamide and streptogramin (MLS) resistance can be conferred by Erm family of 23s rRNA 
methyltransferases (Roberts et al., 1999). These methyltransferases encoded by erm genes (e.g. 
ermA, ermB) are found on plasmid transposons (Hammerum, Flannagan, Clewell, & Jensen, 
2001; Roberts et al., 1999). Although theses resistance genes were not screened in this study, it 
implies that VRE may acquire MLS resistance from these resistant Enterococcus spp. if these 
isolates were exposed to VRE. Furthermore, in reverse, VRE can transfer their van genes to MLS 
or nitrofurantoin resistant Enterococcus spp. from these foods, which would lead to the 
emergence of serious AMR.   
Most of MDR bacteria were isolated from frozen samples. Although the origin of these 
organisms in these foods is not known, feces, irrigation water, sewage sludge in soil or people 
handling the product may have been the source of contamination (Araújo et al., 2017; Ashby et 
al., 2003; Eltai et al., 2018; Rahube et al., 2014, 2016; Tan et al., 2014; Yalçin et al., 2001). 
Fluctuation of temperature during long-distance transit may have allowed the contaminants to 
survive longer in frozen foods than in dried foods (Allen et al., 2013; McKellar et al., 2012). 
Especially, texture of leafy vegetables (chopped spinach, pepper leaves, sweet potato leaves) 
from this study may have become much softer due to thaw by temperature fluctuation allowing 
the contaminants to infiltrate into these foods and survive better (Brown, 1977). For dried foods, 
foodborne bacteria (e.g. E. coli, Salmonella spp.) are reported to survive in low-moisture foods 
(e.g. powder, seeds, peanuts) (Beuchat et al., 2013). However, it is hard for most of bacteria to 
survive in dried foods with long-term low moisture during transportation from country of origin 
to Canada, 
Overall, this study identified and characterized AMR from imported vegetables and spices in 
Canada and provided new insight on these items as a source of AMR. The results emphasize the 
need of up-to-date epidemiological information from countries of origin for better AMR tracking. 
This study, therefore, will provide fundamental data on antimicrobial resistance surveillance 
policy to alleviate resistance transmission from overlooked sources.      
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4. General Discussion and Conclusion 
4.1. Summary of this study 
AMR has become one of the important public health problems and is emerging in humans, 
animals (companion and agricultural) and the environment (wildlife, wastewater) (Doi et al., 
2017). Food has been reported to harbour resistant organisms and mobile resistance genes. In 
Canada, CIPARS monitors resistance in enteric bacteria including, E. coli, Salmonella spp. and 
Campylobacter spp. from food animals and meat products. Unfortunately, other potential 
contaminant bacteria have been not targeted at all in routine surveillance. For example, a couple 
of studies has reported MRSA and levofloxacin and clindamycin resistant C. difficile in 
domestically produced meats (Narvaez-Bravo et al., 2016; Rodriguez-Palacios et al., 2007). 
Another limitation of CIPARS is it focuses on locally available meats without specifically 
targeting those products which include imported contents. Independent studies have identified 
resistant organisms and mobile resistance genes from other types of food such as both domestic 
and imported vegetables and seafood (Allen et al., 2013; Bezanson et al., 2008; Janecko et al., 
2016; Mangat et al., 2016; Morrison & Rubin, 2015; Wood et al., 2015). MDR have been 
identified on imported products including penicillin resistant E. faecium from imported 
vegetables and carbapenemase producing Pseudomonas, Stenotrophomonas and Myroides spp. 
from imported seafoods (Allen et al., 2013; Morrison & Rubin, 2015). However, considering that 
food can be imported from the countries with a high prevalence of AMR, monitoring through the 
national surveillance program and additional targeted studies by independent researchers are 
needed for understanding the risk of AMR through imported foods. Furthermore, there has been 
no study specifically targeting resistant bacteria from imported vegetables and spices in Canada. 
This study identified and characterized resistant Enterobacteriaceae, meropenem resistant Gram-
negatives, S. aureus and Enterococcus spp. isolated from imported vegetables and spices as a 
pilot investigation to address this gap.       
 Emerging multidrug resistant Enterobacteriaceae (E. coli, Enterobacter spp. and K. 
pneumoniae) conferred by ESBL and PMQR determinants were identified. The foods containing 
these resistant bacteria were all imported from China, Bangladesh and India. Most of meropenem 
and colistin resistant Acinetobacter spp. and Pseudomonas spp. were also identified from the 
foods imported from China, Bangladesh, India, Vietnam and the Philippines. All MRSA were 
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isolated from the foods imported from the Philippines. Interestingly, most of foods that had these 
important MDR bacteria were imported from Asian countries which have the highest rate of 
AMR in the world (Chereau, Opatowski, Tourdjman, & Vong, 2017; World Health Organization, 
2016b; Yezli & Li, 2012). This suggests that imported foods can be one of the routes for transfer 
of resistance from high prevalence of countries to low prevalence of countries. Even though this 
study is not aiming to discuss the surveillance policies in high use of drugs and prevalence of 
resistance countries, the situation in country of origins will be discussed briefly. 
 
4.2. Trend of resistance and counteraction from countries of origin 
Although this investigation was not designed to compare the frequency of resistance 
between countries, it was interesting that resistant organisms were most commonly isolated from 
products of China. Future studies focused on identifying significant epidemiological relationships 
between geographic regions and the presence of resistant organisms should be done. 
China is the second biggest producer and consumer of antibiotics, and antibiotic use for 
treatment in humans and animal and growth promotion in animals is vast (Van Boeckel et al., 
2014; Zhang, Ying, Pan, Liu, & Zhao, 2015). Consequently, large quantities of antibiotics 
released into the environment through manure, and via rivers through sewage effluent are thought 
to have contributed to the rapid emergence of resistance (Li, Shi, Gao, Liu, & Cai, 2013; Xu et 
al., 2016; Zhang, Luo, Wu, Huang, & Christie, 2015; Zhou et al., 2013). To reduce the overuse of 
antimicrobials and emergence of resistance, collaboration between institutions from China and 
Sweden (The Sino-Swedish integrated multi-sectorial partnership for antibiotic resistance 
containment) has made to identify antibiotic use and resistance in rural area of China from 2014 
to 2018 (Cars et al., 2016). China has also entered into an agreement with the UK to establish 
bilateral fund for tackling AMR in 2016 and they are currently aiming to take an action in 2019 
(Global and Public Health Group, 2017). On a national level, the Chinese Government 
announced a national action plan to act against AMR in 2016 (National Health Commission of 
the People’s Republic of China, 2016; Xiao & Li, 2016). While their plan is designed to prevent 
overuse of antibiotics, resistance control and novel antimicrobial development, this is a complex 
problem and challenges still exist. Even though National Health Commission (NHFPC) is 
currently working on a five-year plan (covering 2016 to 2020) no interim reports have been 
75 
 
published, making evaluation of progress impossible (National Health Commission of the 
People’s Republic of China, 2016). Furthermore, since animal agriculture in China is a huge 
industry, there will undoubtedly be a lot of challenges to regulate antimicrobial use practices 
from industry. Similar to resistance surveillance systems in North America, the Chinese action 
plan focuses on identifying the presence of resistant organisms in animal origin food products. 
(National Health Commission of the People’s Republic of China, 2016). As the current study 
identified ESBLs, PMQRs and class I integrons, we suggest that other types of food need to be 
targeted to prevent their domestic and international spread.  
Bangladesh is also a country of high prevalence of AMR. Challenges in the regulation of 
appropriate antimicrobial use in Bangladesh including the availability of antimicrobials over the 
counter, are widely thought to have contributed to the high prevalence of AMR (Fahad, Matin, 
Shill, & Asish, 2010; Lina, Rahman, & Gomes, 2007). Overcrowding, lack of basic sanitary 
facilities in rural areas (ex. the use of unsanitized latrines, lack of effective wastewate treatment, 
living with livestock in same house) and a mobile population are also reported to contribute to 
resistance dissemination in Bangladesh (Bakshi, Mallick, & Ulubaşoğlu, 2015; Lina et al., 2007). 
Even though independent researchers have done studies to identify resistance, there is no national 
surveillance data available in Bangladesh (World Health Organization, 2014). Although 
researchers in Bangladesh have found important resistance including carbapenemase producers 
(NDM-1, OXA-48, OXA-181, KPC, IMP, VIM), a systematic surveillance system to tackle 
AMR problem has yet to be established (Begum & Shamsuzzaman, 2016). Although serious 
resistance such as carbapenemase was not identified from this study, it indicates that other 
important resistance determinants, ESBL, PMQR and class I integrons, exist in domestically 
consumed and exported vegetable products.  
Philippines was another country from which foods containing meropenem resistant P. 
monteilii and MRSA were isolated. Although there is a surveillance program and studies that 
identified carbapenem resistant P. aeruginosa from the Philippines, no study has identified 
carbapenem resistant P. monteilii (Antimicrobial Resistance Surveillance Reference Laboratory, 
2018; Tesalona, Lagamayo, & Cabal, 2017; Tesalona, Lagamayo, Evangelista, et al., 2017). As 
P. monteilii is usually found in the environment, the meropenem resistant isolate from this study 
may lead to new investigations to improve our understanding of the distribution of 
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carbapenemases producers in environmental settings that can lead to human exposure. MRSA 
isolated from vegetables imported from the Philippines also suggests that there is a need for 
broader investigations besides human clinical settings for the detection of MRSA. MRSA isolates 
were identified from samples that are processed and packaged in Philippines. Even though STs of 
MRSA isolates from this study are not reported from the Philippines, they may be circulating in 
their environment. Furthermore, considering that these STs were isolated from human patients 
around the world, these MRSA isolates might have traveled to the Philippines via international 
travellers. 
Although not many resistant bacteria were identified from products originating in India, 
MDR bacteria isolated from two samples are reported to be infamous superbugs, which were 
ESBL producing K. pneumoniae and meropenem and colistin resistant A. baumannii. India is 
reported to be the largest producer and consumer of antibiotics in the world (Van Boeckel et al., 
2014). Along with overuse of antimicrobials including penicillins, cephalosporins and 
quinolones, multiple factors including high burden of disease, and poor public health 
infrastructure may have accelerated emergence of the resistance in India (Global Antibiotic 
Resistance Partnership - India Working Group, 2011; Laxminarayan & Chaudhury, 2016). A 
national action plan to tackle their severe resistance problem was developed in 2017 by the 
Government of India with an implementation period of 2017 through 2021 (Government of India, 
2017). While the plan is systematic and includes surveillance targetting fruits and vegetables, 
improvements in the surveillance infrastructure may need to be made before the full potential of 
this program can be realized (Das, Chaudhuri, Srivastava, Nair, & Ramamurthy, 2017; 
Government of India, 2017). India previously had an Antimicrobial Resistance Surveillance and 
Research Network as a main surveillance program which was launched in 2013 (Das et al., 
2017). However, gaps caused by inadequate financial resources for the participating health 
institutions and difficulty coordinating health systems have been crucial obstacles for efficient 
surveillance in India (Das et al., 2017; Lakshminarayanan, 2011). More frequent international 
collaboration also needs to be done for intervening the international level of resistance 
transmission via travellers (e.g. human, animals) and import/export goods (e.g. foods).   
 Other foods imported from Vietnam, Egypt and Cameroon contained meropenem and 
colistin resistant oxidase positive bacteria which had no carbapenemase or mobile colistin 
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resistance determinants. There has been no national resistance surveillance program in 
Cameroon. Studies by independent researchers have been limited to human patients (World 
Health Organization, 2014). International action to establish an effective surveillance program in 
Cameroon among the other countries in Africa and Asia has been ongoing; Cameroon was 
funded by WHO Advisory Group on Integrated Surveillance of Antimicrobial Resistance 
(AGISAR) for investigation on resistant foodborne pathogens and establishment of national 
surveillance in 2010 and 2012 (World Health Organization, 2018). The plans by AGISAR are 
promising since they are developing surveillance targeting not only humans but also the food 
chain and the environment (World Health Organization, 2016a). However, problematic factors 
including high burden of disease, poor infrastructure of the health care system and wars in 
Cameroon are huge obstacles to implementing the AGISAR plans (Kesah & Payne, 2013). 
Therefore, more support is needed at an international level to overcome these challenges. There 
also needs to be cooperation between researchers from Cameroon and other countries with well-
established surveillance systems.   
 All MDR organisms that harboured transferrable resistance genes (ESBL, PMQR 
determinants genes) were isolated from the foods imported from the countries that have a high 
prevalence of AMR. As Canada is recognized to have a relatively of low prevalence of AMR, 
transmission of organisms from the countries with a high prevalence of AMR may cause increase 
of the prevalence in Canada. As these organisms harboured transferrable resistance genes, the 
genes could be transferred to other organisms. Further investigation, such as quantification of the 
resistant organisms from imported foods, should be done to determine the possibility of infection 
and transfer of resistance. As we also lack the information on prevalence of AMR in domestic 
vegetables and spices, investigation of the prevalence in domestic foods are needed. These results 
then need to be compared with imported foods to provide a better understanding how impactful 
AMR transmission via imported foods is on the prevalence of AMR in Canada. Furthermore, 
international research collaboration between Canada and the exporting countries would give 
better understanding of AMR transmission and bring better prevention methods in international 
level.  
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4.3. Limitation of the study and future directions 
Because it was a pilot study, there are several recognized limitations of this investigation; 
the number of food samples, countries of origin, and timeline of the investigation. 147 samples 
were only a small portion of imported vegetables and spices that are distributed in the 
international markets in Saskatoon. Our collection of imported vegetables and spices may not be 
representative of all the products which are distributed across Canada or even our region. There is 
the possibility that a larger more representative sampling would have revealed more MDR 
bacteria especially the critical MDR organisms such as carbapenemase producers, MCR genes 
and VRE. Countries of origin were mostly Asian and African countries and there were no 
countries of origin from Central and South America, Europe and Oceania. It is possible that VRE 
might exist in vegetables imported from European countries as their studies reported VRE is still 
being identified in broiler flocks (Bortolaia et al., 2015). Considering the possibility of 
contamination from broiler to vegetables, VRE could be identified from their vegetables and 
transmitted into Canada through imported products. The results could also have been impacted if 
the timeline of the study was longer. It would also be useful to have had data regarding the 
seasons in which the food was harvested. An investigation from Benin identified seasonality (dry 
vs. rainy season) as a factor impacting the prevalence of resistance detection (Moussé et al., 
2015).  
Furthermore, the laboratory approaches used to isolate bacteria did not allow for a holistic 
view of the microbial community from the food samples. First, it was not possible to quantify 
bacterial load because selective broths were used indicating that contamination level of the food 
with MDR isolates may have been very low (Lipstich & Samore, 2002). Next, although we 
endeavoured to characterize a wider variety of organisms than are included in current national 
level surveillance programs, however, culture-based investigations are always limited to a set of 
bacterial species. It is possible that our methodological approach which excluded Campylobacter 
spp., Clostridium difficile or other clinically relevant organisms may have under estimated the 
true prevalence of resistance.  
Another limitation is missing unculturable organisms as vegetables and spices, especially 
root-types, which were likely to be in contact with the soil that has diverse microbiome. Not only 
were these organisms unable to be isolated by any selective media, but also it is impossible to 
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identify and characterize their resistance. The possible solution for this may be next generation 
sequencing (NGS). NGS is state-of-the-art technology able to sequence entire genomes of the 
microbiome and analyze specific DNA or RNA of interests (metagenomics, transcriptomics) 
(Angers-Loustau et al., 2018; Behjati & Tarpey, 2013; Tavares et al., 2013). However, it is 
limited to predict the phenotypic resistance based on genotype analysis. The utility of NGS 
approaches in identifying the presence of resistance requires further study, the agreement 
between this approach and phenotypically derived MICs has not been adequately investigated in 
the context of microbal communities. 
 
4.4. Future plans and conclusions 
 This study highlighted gaps in our knowledge which should be addressed by future 
investigations.  
As the information of the presence of AMR in domestically produced vegetables and spices 
is lacking, future studies targeting AMR in domestically produced plant-based foods are 
encouraged. A comparison of domestically produced and imported foods is required for a 
complete understanding of the epidemiology of foodborne resistance.  
Another potential plan would be developing NGS tools for better identification of AMR. 
Although it is possible to identify whole chromosomal genome and mobile gene elements with 
NGS, it may be challenging to predict transferability of resistance genes due to the difficulty of 
linking mobile gene elements to genomes of individual organisms in whole microbiome 
(Goordial & Ronholm, 2018). While NGS approaches may not reliably predict phenotypic 
reistance (MIC) in an individual organism, when used in combination with classical approaches, 
they do have the ability to add information about the presence of resistance genes in unculturable 
members of the microbial community (Bishara et al., 2018; Goordial & Ronholm, 2018).  
Lastly, partnering with our national surveillance program would make improvements to 
surveillance in Canada. Along with the past studies by Canadian researchers, the findings from 
this study will provide evidence that clinically relevant MDR bacteria can be also identified from 
foods other than domestic meat (Allen et al., 2013; Bezanson et al., 2008; Morrison & Rubin, 
2015). This is very crucial since national surveillance programs are able to regularly and 
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systematically monitor resistance to provide accurate estimates of population prevalence, which 
is challenging for independent researchers. Although not a CIPARS activity, government 
scientists have recently worked to target imported foods; interestingly carbapenemase producers 
including VCC-1 producing V. cholerae was identified from imported shrimp (Public Health 
Agency of Canada, 2018a). In the CARSS report, the possibility of resistance transmission 
through imported food was recognized, highlighting the importance of additional collaboration 
between independent researchers and the national surveillance program (Public Health Agency of 
Canada, 2018a). 
   In conclusion, imported vegetables and spices are a source for transmitting clinically 
important MDR bacteria including ESBL, PMQR determinants within Enterobacteriaceae and 
MRSA. MDR was identified primarily from foods imported from the countries having a high 
prevalence of AMR. Future research to identify resistance from a larger number of imported 
vegetables and spices and to compare resistance trends between imported and domestically 
produced vegetables and spices needs to be conducted. There are clearly outstanding questions 
regarding the epidemiology of resistance at the national level. Continued, enriched collaboration 
between independent researchers and federal agencies is essential to generate evidence for the 
development of effective intervention strategies to prevent AMR transmission.    
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Appendix  
 List of Companies 
Antibiotics 
A. Sandoz Canada Inc. (Boucherville, Quebec, Canada)  
Meropenem  
B. Sigma-Aldrich (St. Louis, Missouri, USA) 
  Colistin Sulfate Salt 
Antimicrobial Susceptibility testing 
C. Automed Inc. (St. Paul, Minnesota, USA) 
  Cathra Replicator 
D. Trek Diagnostics (Cleveland, Ohio, USA) 
  Dimineralized water 
  Cation-adjusted Mueller-Hinton broth 
Sensititre Automated Inoculation System 
E. ThermoFisher Scientific (Waltham, Massachusetts, USA) 
  CMV4AGNF plate for Gram-negative 
  GPALL1F plate for Gram-positive 
Bacteria growth media 
F. Beckton Dickson (Sparks, Maryland, USA) 
  BBLTM EnterococcoselTM Agar 
BBLTM EnterococcoselTM Broth 
  BBLTM Mannitol Salt Agar 
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  BBLTM Mueller Hinton II Agar 
BBLTM Tetrathionate Broth Base 
  BDTM Rappaport Vassiliadis Broth 
  BDTM Tryptic Soy Broth 
  DifcoTM Brilliant Green Agar 
DifcoTM Buffered Peptone Water 
   DifcoTM XLD Agar 
G. CHROMagar (Paris, France) 
  CHROMagarTM ESBL 
H. Sigma-Aldrich (St. Louis, Missouri, USA) 
  MacConkey Broth 
I. Thermo Fisher Oxoid (Basingstoke, Hampshire, England) 
  Columbia Blood Agar with 5% Sheep Blood 
  Thermo ScientificTM Eosin Methylene Blue agar (Levine) 
Biochemical test 
J. Beckton Dickson (Sparks, Maryland, USA) 
BactoTM Tryptone (for indole)  
BBLTM Coagulase Plasma, Rabbit with EDTA 
  BBLTM DrySlideTM Oxidase 
BBLTM Simmons Citrate Agar Slants 
BBLTM Sodium Hippurate Broth 
  BBLTM TSI Agar Slants 
K. Bio-Rad (Hercules, California, USA) 
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  β CARBA test 
L. Hardy Diagnostics (Santa Maria, California, USA) 
  PYR Test Kit 
M. Thermo Fisher Oxoid (Basingstoke, Hampshire, England) 
  Urea Agar Base  
PCR 
N. Bio Basic Canada Inc. (Markham, Ontario, Canada) 
  EX-10 Spin Column PCR Purification kit 
O. Bio-Rad (Hercules, California, USA) 
  C1000 Touch Thermal Cycler 
  Gel Doc XR+ 
P. GE Healthcare (Little Chalfont, Buckinghamshire, England) 
  Illustra ExoProStar kit 
Q. Invitrogen (Carlsbad, California, USA) 
  Taq DNA Polymerase, recombinant 
R. ThermoFisher Scientific (Waltham, Massachusetts, USA) 
  Nanodrop 2000 Spectrophotometer 
 
 
 
 
 
